Release 5 Preview #3
TerminologyThis page is part of the FHIR Specification (v4.5.0: R5 Preview #3). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions 
. Page versions: R5 R4B R4 R3 R2
| Patient Care Work Group | Maturity Level: 1 | Draft | Use Context: Any |
This is a value set defined at http://www.hl7.org/Special/committees/patientcare/ .
Summary
| Defining URL: | http://hl7.org/fhir/ValueSet/condition-stage |
| Version: | 4.5.0 |
| Name: | ConditionStage |
| Title: | Condition Stage |
| Definition: | Example value set for stages of cancer and other conditions. |
| Committee: | Patient Care Work Group |
| OID: | 2.16.840.1.113883.4.642.3.170 (for OID based terminology systems) |
| Copyright: | This resource includes content from SNOMED Clinical Terms® (SNOMED CT®) which is copyright of the International Health Terminology Standards Development Organisation (IHTSDO). Implementers of these specifications must have the appropriate SNOMED CT Affiliate license - for more information contact http://www.snomed.org/snomed-ct/get-snomed-ct or info@snomed.org |
| Source Resource | XML / JSON |
This value set is used in the following places:
http://snomed.info/sct where concept is-a 385356007 (Tumour stage finding)
This expansion generated 20 Aug 2020
This value set has >1000 codes in it. In order to keep the publication size manageable, only a selection (1000 codes) of the whole set of codes is shown
All codes from system http://snomed.info/sct
| Code | Display | Definition |
| 786005 | Clinical stage I B | |
| 1523005 | Clinical stage IV B | |
| 2640006 | Clinical stage 4 | |
| 2786004 | Epithelial ovarian tumor, International Federation of Gynecology and Obstetrics stage III | |
| 5701003 | Lymphoma stage IIe | |
| 5856006 | N3 stage | |
| 6123003 | pT4 stage | |
| 6534007 | Epithelial ovarian tumor, FIGO stage IIA | |
| 13104003 | Clinical stage I | |
| 14410001 | Tumor stage T3 | |
| 14926007 | pM1: Distant metastasis | |
| 14927003 | FIGO VC stage II | |
| 15076001 | pN2 category | |
| 15540006 | International Federation of Gynecology and Obstetrics cervical cancer (FIGO CC) stage I | |
| 15542003 | Clinical stage I C | |
| 17076002 | pMX: Distant metastasis cannot be assessed | |
| 17691001 | Clinical stage I S | |
| 17816005 | Clinical stage II B | |
| 19408000 | pM0: No distant metastasis | |
| 21917009 | pN0 category | |
| 22079002 | N4 category | |
| 22364004 | International Federation of Gynecology and Obstetrics vulvar carcinoma (FIGO VC) stage III | |
| 23351008 | Tumor stage T1 | |
| 25654007 | International Federation of Gynecology and Obstetrics cervical cancer (FIGO CC) stage Ib | |
| 27167007 | Metastasis stage MX | |
| 30382004 | International Federation of Gynecology and Obstetrics endometrial cancer (FIGO EC) stage II | |
| 30440004 | Lymphoma stage I | |
| 30893008 | Metastasis stage M0 | |
| 31747005 | Modified Dukes stage B1 | |
| 33177002 | Clinical stage IV C | |
| 33907000 | Clinical stage III E | |
| 34537009 | International Federation of Gynecology and Obstetrics endometrial cancer (FIGO EC) stage IV | |
| 35440002 | Clinical stage I D | |
| 36018006 | Epithelial ovarian tumor, International Federation of Gynecology and Obstetrics stage IA | |
| 37415008 | Epithelial ovarian tumor, International Federation of Gynecology and Obstetrics stage IC | |
| 39617003 | Clinical stage II C | |
| 39880006 | pT0 category | |
| 43189003 | pTX category | |
| 44255004 | Lymphoma stage IIIe | |
| 44401000 | Tumor stage Tis | |
| 45552005 | pN1 category | |
| 46059003 | Node stage N2 | |
| 46333007 | Clinical stage 1 A | |
| 46756001 | International Federation of Gynecology and Obstetrics endometrial cancer (FIGO EC) stage I A | |
| 48105005 | Clinical stage 3 C | |
| 49182004 | pN3 category | |
| 49219005 | International Federation of Gynecology and Obstetrics cervical cancer (FIGO CC) stage Ia | |
| 50237009 | International Federation of Gynecology and Obstetrics endometrial cancer (FIGO EC) stage I | |
| 50283003 | Clinical stage III | |
| 52708004 | International Federation of Gynecology and Obstetrics cervical cancer (FIGO CC) stage III | |
| 52774001 | Clinical stage 2 A | |
| 52865009 | Clinical stage IV D | |
| 53173007 | Modified Dukes stage B2 | |
| 53623008 | Node stage N1 | |
| 53786006 | pT1 category | |
| 54452005 | pNX category | |
| 54498006 | Modified Dukes stage C1 | |
| 55336000 | Clinical stage III D | |
| 55440008 | Metastasis stage M1 | |
| 56380009 | Clinical stage I E | |
| 56587006 | International Federation of Gynecology and Obstetrics vulvar carcinoma (FIGO VC) stage I | |
| 56769006 | Modified Dukes stage A | |
| 56944001 | Lymphoma stage III | |
| 57306005 | Modified Dukes stage C2 | |
| 57605004 | Modified Dukes stage D | |
| 58790005 | Tumor stage T0 | |
| 60275007 | FIGO EC stage I B | |
| 60333009 | Clinical stage II | |
| 62455006 | N0 stage | |
| 64062008 | Clinical stage III B | |
| 64202001 | Clinical stage IV E | |
| 64574000 | Epithelial ovarian tumor, FIGO stage IIB | |
| 64737002 | Epithelial ovarian tumor, FIGO stage IB | |
| 64877001 | Clinical stage III S | |
| 65235001 | Epithelial ovarian tumor, FIGO stage I | |
| 65306007 | FIGO VM stage II | |
| 65536004 | FIGO VM stage III | |
| 65565005 | T4 stage | |
| 66445009 | Lymphoma stage IV | |
| 67101007 | TX stage | |
| 67673008 | T2 stage | |
| 68240008 | FIGO CC stage II | |
| 69605008 | Clinical stage II E | |
| 70046009 | FIGO VM stage I | |
| 70664003 | Clinical stage IV S | |
| 71725004 | Clinical stage IV A | |
| 72780008 | FIGO VC stage IV | |
| 73055006 | FIGO VM stage V | |
| 73082003 | Clinical stage III A | |
| 73511008 | Epithelial ovarian tumor, FIGO stage IV | |
| 74053007 | Lymphoma stage IIIs | |
| 75339006 | Lymphoma stage III 2 | |
| 76422004 | Lymphoma stage II | |
| 78199001 | Epithelial ovarian tumor, FIGO stage IIC | |
| 78607009 | Epithelial ovarian tumor, FIGO stage II | |
| 79420006 | Node stage NX | |
| 80588003 | FIGO VM stage IV | |
| 80663004 | pN4 stage | |
| 80898003 | pT2 stage | |
| 80975007 | FIGO EC stage III | |
| 81822003 | FIGO CC stage IV | |
| 84633001 | Lymphoma stage IIIse | |
| 84921008 | pTis stage | |
| 87977001 | International Federation of Gynecology and Obstetrics cervical cancer stage Ib occ | |
| 89487002 | Lymphoma stage Ie | |
| 90321006 | Clinical stage II S | |
| 90402004 | pT3 stage | |
| 112240001 | Clinical stage II D | |
| 112241002 | Lymphoma stage III 1 | |
| 258297005 | Metastasis stage M2 | |
| 258298000 | Metastasis stage M3 | |
| 258299008 | Metastasis stage M4 | |
| 261646003 | Tumor stage T1a | |
| 261647007 | Tumor stage T1a1 | |
| 261648002 | Tumor stage T1a2 | |
| 261649005 | Tumor stage T1b | |
| 261650005 | Tumor stage T1c | |
| 261651009 | Tumor stage T2a | |
| 261652002 | Tumor stage T2b | |
| 261653007 | Tumor stage T2c | |
| 261654001 | Tumor stage T3a | |
| 261655000 | Tumor stage T3b | |
| 261656004 | Tumor stage T3bi | |
| 261657008 | Tumor stage T3bii | |
| 261658003 | Tumor stage T3c | |
| 261659006 | Tumor stage T4a | |
| 261660001 | Tumor stage T4b | |
| 261661002 | Tumor stage T4c | |
| 261662009 | Tumor stage T4d | |
| 261927002 | Metastasis stage M1a | |
| 261928007 | Metastasis stage M1b | |
| 261929004 | Metastasis stage M1c | |
| 261967001 | Node stage N2a | |
| 261968006 | Node stage N2b | |
| 261969003 | Node stage N2c | |
| 277672002 | Node stage N1a | |
| 277674001 | Node stage N1b | |
| 277744001 | Metastasis stage pM1 | |
| 277772008 | Node stage N1bi | |
| 277776006 | Node stage N1bii | |
| 277777002 | Node stage N1biii | |
| 277778007 | Node stage N1biv | |
| 313108002 | Tumor stage T1mic | |
| 313110000 | Tumor stage T1b1 | |
| 313111001 | Tumor stage T1b2 | |
| 313145008 | Tumor stage Tis pu | |
| 313146009 | Tumor stage Tis pd | |
| 369793000 | Tis (--): Carcinoma in situ (endometrium / uterine cervix) | |
| 369794006 | T1 (I): Cervical carcinoma confined to uterus | |
| 369795007 | T1a (IA): Invasive carcinoma of uterine cervix diagnosed by microscopy only | |
| 369796008 | T1a1 (IA1): Tumor of uterine cervix with stromal invasion < 3.0 mm in depth and horizontal spread < 7.0 mm | |
| 369797004 | T1a2 (IA2): Tumor of uterine cervix with stromal invasion > 3.0 mm but < 5.0 mm in depth and horizontal spread < 7.0 mm | |
| 369798009 | T1b (IB): Tumor of uterine cervix with clinically visible lesion confined to the cervix or microscopic lesion greater than T1a2/IA2 | |
| 369799001 | T1b1 (IB1): Tumor of uterine cervix, clinically visible lesion < 4.0 mm in greatest dimension | |
| 369800002 | T1b2 (IB2): Tumor of uterine cervix, clinically visible lesion > 4.0 mm in greatest dimension | |
| 369801003 | T2 (II): Tumor of uterine cervix invades beyond the uterus but not to pelvic wall or to lower third of vagina | |
| 369802005 | T2a (IIA): Tumor of uterine cervix, T2 without parametrial invasion | |
| 369803000 | T2b (IIB): Tumor of uterine cervix, T2 with parametrial invasion | |
| 369804006 | T3 (III): Tumor of uterine cervix extends to the pelvic wall and/or involves the lower third of the vagina and/or causes hydronephrosis or nonfunctioning kidney | |
| 369805007 | T3a (IIIA): Tumor of uterine cervix involves lower third of vagina, but not pelvic wall | |
| 369806008 | T4 (IVA): Tumor of uterine cervix/vagina invades mucosa of bladder or rectum and/or extends beyond true pelvis | |
| 369807004 | T1 (I): Endometrial tumor confined to corpus uteri | |
| 369808009 | T1a (IA): Tumor limited to endometrium | |
| 369809001 | T1b (IB): Endometrial tumor invades up to or less than one half of the endometrium | |
| 369810006 | T1c (IC): Endometrial tumor invades to more than one half of the endometrium | |
| 369811005 | T2 (II): Endometrial tumor invades cervix, but does not extend beyond uterus | |
| 369812003 | T2a (IIA): Endometrial tumor with endocervical glandular involvement | |
| 369813008 | T2b (IIB): Endometrial tumor with cervical stromal invasion | |
| 369814002 | T3 (III): Endometrial tumor with local and/or regional spread as specified in T3a, b, N1 and FIGO IIIA, B, and C below or adnexa (direct extension or metastasis) and/or cancer cells in ascites or peritoneal washings | |
| 369815001 | T3b (IIIB): Endometrial tumor with vaginal involvement (direct extension or metastasis) | |
| 369816000 | T4 (IVA): Endometrial tumor invades bladder mucosa and/or bowel mucosa | |
| 369817009 | T1 (I): Tumor confined to vagina | |
| 369818004 | T2 (II): Vaginal tumor invades paravaginal tissues but not to pelvic wall | |
| 369819007 | T3 (III): Vaginal tumor extends to pelvic wall | |
| 369820001 | T1 (I): Tumor limited to fallopian tube(s) | |
| 369821002 | T1a (IA): Tumor limited to one fallopian tube without penetrating the serosal surface, no ascites | |
| 369822009 | T1b (IB): Tumor limited to both tubes without penetrating the serosal surface: no ascites | |
| 369823004 | T1c (IC): Tumor limited to one or both tube(s) with extension into or through the tubal serosa; or with malignant cells in ascites or peritoneal washings: FALLOPIAN TUBE: Salpingectomy | |
| 369824005 | T2 (II): Fallopian tube tumor involves one or both tube(s) with pelvic extension | |
| 369825006 | T2a (IIA): Fallopian tube tumor with extension and/or metastasis to the uterus and/or ovaries | |
| 369826007 | T2b (IIB): Fallopian tube/ovarian tumor with extension to other pelvic structures | |
| 369827003 | T2c (IIC): Fallopian tube/ovarian tumor with pelvic extension (T2a or b) with malignant cells in ascites or peritoneal washings | |
| 369828008 | T3 and/or N1 (III): Fallopian tube tumor involves one or both tube(s) with peritoneal implants outside the pelvis and/or regional lymph node metastasis | |
| 369829000 | T3a (IIIA): Fallopian tube/ovarian tumor with microscopic peritoneal metastasis beyond pelvis | |
| 369830005 | T3b (IIIB): Fallopian tube/ovarian tumor with macroscopic peritoneal metastasis beyond pelvis < 2 cm in greatest dimension | |
| 369831009 | T3c (IIIC): Fallopian tube/ovarian tumor with peritoneal metastasis beyond pelvis > 2 cm in greatest dimension and/or regional lymph node metastasis | |
| 369832002 | T1: Clinically inapparent prostate tumor not palpable or visible by imaging | |
| 369833007 | T1a: Prostate tumor incidental histologic finding in 5% or less of tissue resected | |
| 369834001 | T1b: Prostate tumor incidental histologic finding in > 5% of tissue resected | |
| 369835000 | T1c: Tumor identified by needle biopsy because of elevated prostate specific antigen: PROSTATE: Biopsy/transurethral resection: PROSTATE: Resection | |
| 369836004 | T2a: Prostate tumor involves one lobe | |
| 369837008 | T3: Prostate tumor extends through the prostatic capsule | |
| 369838003 | T3a: Prostate tumor with extracapsular extension (unilateral or bilateral) | |
| 369839006 | T3b: Prostate tumor invades the seminal vesicle(s) | |
| 369840008 | T2: Aerodigestive tract tumor causing bone erosion or destruction, except for the posterior antral wall, including extension into hard palate and/or middle nasal meatus | |
| 369841007 | T1: Aerodigestive tract tumor < 2 cm in greatest dimension | |
| 369842000 | T1: Aerodigestive tract tumor confined to ethmoid with or without bone erosion | |
| 369843005 | T1: Aerodigestive tract tumor confined to nasopharynx | |
| 369844004 | T1: Tumor limited to one subsite of hypo-pharynx and < 2 cm in greatest dimension | |
| 369845003 | T1: Tumor limited to one subsite of supraglottis with normal vocal cord mobility | |
| 369846002 | T1: Tumor limited to subglottis | |
| 369847006 | T1: Tumor limited to the antral mucosa with no erosion or destruction of bone | |
| 369848001 | T1: Tumor limited to vocal cord(s) (may involve anterior or posterior commissure) with normal mobility | |
| 369849009 | T1a: Tumor limited to one vocal cord | |
| 369850009 | T1b: Tumor involves both vocal cords | |
| 369851008 | T2: Aerodigestive tract tumor > 2 cm but < 4 cm in greatest dimension | |
| 369852001 | T2: Aerodigestive tract tumor > 2 cm but < 4 cm in greatest dimension without extraparenchymal extension | |
| 369853006 | T2: Aerodigestive tract tumor extends into nasal cavity | |
| 369854000 | T2: Aerodigestive tract tumor extends to soft tissue of oropharynx and/or nasal fossa | |
| 369855004 | T2: Aerodigestive tract tumor extends to supraglottis and/or subglottis, and/or with impaired vocal cord mobility | |
| 369856003 | T2: Aerodigestive tract tumor extends to vocal cord(s) with normal or impaired mobility | |
| 369857007 | T2: Aerodigestive tract tumor invades more than one subsite of hypopharynx or an adjacent site, or measures > 2 cm but < 4 cm in greatest dimension, without fixation of hemilarynx | |
| 369858002 | T2: Aerodigestive tract tumor invades mucosa of >1 adjacent subsite of supraglottis/glottis/region outside supraglottis, (mucosa of base of tongue/vallecula/medial wall of piriform sinus) without fixation of larynx | |
| 369859005 | T2a: Aerodigestive tract tumor without parapharyngeal extension | |
| 369860000 | T2b: Aerodigestive tract tumor with parapharyngeal extension | |
| 369861001 | T3: Aerodigestive tract tumor > 4 cm in greatest dimension | |
| 369862008 | T3: Aerodigestive tract tumor extends to anterior orbit and/or maxillary sinus | |
| 369863003 | T3: Aerodigestive tract tumor having extraparenchymal extension without seventh nerve involvement, and/or > 4 cm but < 6 cm in greatest dimension | |
| 369864009 | T3: Aerodigestive tract tumor invades any of the following: bone of posterior wall of maxillary sinus, subcutaneous tissues, skin of cheek, floor or medial wall of orbit, infratemporal fossa, pterygoid plates, ethmoid sinuses | |
| 369865005 | T3: Aerodigestive tumor invades bony structures and/or paranasal sinuses | |
| 369866006 | T3: Aerodigestive tract tumor limited to larynx with vocal cord fixation | |
| 369867002 | T3: Aerodigestive tract tumor limited to larynx with vocal cord fixation and/or invades any of the following: postcricoid area, pre-epiglottic tissues, deep base of tongue | |
| 369868007 | T3: Aerodigestive tract tumor measures > 4 cm in greatest dimension, or with fixation of hemilarynx | |
| 369869004 | T4: Lip: Tumor invades adjacent structures (cortical bone, inferior alveolar nerve, floor of mouth, skin of face) | |
| 369870003 | T4: Oral Cavity: Tumor invades adjacent structures (cortical bone, deep (extrinsic) muscle of tongue, maxillary sinus, skin) | |
| 369871004 | T4: Aerodigestive tract tumor invades adjacent structures (pterygoid muscles, mandible, hard palate, deep muscle of tongue, larynx) | |
| 369872006 | T4: Aerodigestive tract tumor invades adjacent structures (thyroid/cricoid cartilage, carotid artery, soft tissues of neck, prevertebral fascia/muscles, thyroid and/or esophagus) | |
| 369873001 | T4: Aerodigestive tumor invades base of skull, seventh nerve, and/or exceeds 6 cm in greatest dimension | |
| 369874007 | T4: Aerodigestive tract tumor invades orbital contents beyond the floor or medial wall including apex and/or any of the following: cribriform plate, base of skull, nasopharynx, sphenoid sinus, frontal sinus | |
| 369875008 | T4: Tumor invades through cricoid or thyroid cartilage and/or extends into other tissues beyond the larynx (trachea, soft tissues of neck, thyroid, esophagus) | |
| 369876009 | T4: Tumor invades through thyroid cartilage and/or extends to other tissues beyond the larynx (trachea, soft tissues of neck, pharynx) | |
| 369877000 | T4: Tumor invades through thyroid cartilage, and/or extends into soft tissues of the neck, thyroid, and/or esophagus | |
| 369878005 | T4: Aerodigestive tract tumor with intracranial extension and/or involvement of cranial nerves, infratemporal fossa, hypopharynx or orbit | |
| 369879002 | T4: Aerodigestive tract tumor with intracranial extension, orbital extension including apex, involving sphenoid and/or frontal sinus and/or skin of nose | |
| 369880004 | T1: Lung tumor 3 cm or less in greatest dimension, surrounded by lung or visceral pleura, without bronchoscopic evidence of invasion more proximal than the lobar bronchus | |
| 369881000 | T2:Lung tumor with any of these features:>3cm in greatest dimension, involves main bronchus >2cm distal to carina; invades visceral pleura; assoc with atelectasis/obstructive pneumonitis extends to hilar region, does not involve entire lung | |
| 369882007 | T3: Lung tumor of any size associated atelectasis or obstructive pneumonitis of the entire lung | |
| 369883002 | T3: Lung tumor of any size in the main bronchus < 2 cm distal to the carina but without involvement of the carina | |
| 369884008 | T3: Lung tumor of any size that directly invades any of the following: chest wall (including superior sulcus tumors); diaphragm; mediastinal pleura; parietal pericardium | |
| 369885009 | T4: Lung tumor of any size that invades any of the following: mediastinum; heart; great vessels; trachea; esophagus; vertebral body; carina | |
| 369886005 | T4: Lung tumor of any size with a malignant pleural effusion | |
| 369887001 | T4: Lung tumor of any size with separate tumor nodule(s) in same lobe | |
| 369888006 | T1: Kidney tumor < 7.0 cm in greatest dimension limited to the kidney | |
| 369889003 | T2: Renal tumor > 7.0 cm in greatest dimension limited to the kidney | |
| 369890007 | T3: Renal tumor extends into major veins or invades the adrenal gland or perinephric tissues but not beyond Gerota fascia | |
| 369891006 | T3a: Renal tumor invades the adrenal gland or perinephric tissues but not beyond Gerota fascia | |
| 369892004 | T3b: Renal tumor grossly extends into the renal vein(s) or vena cava below the diaphragm | |
| 369893009 | T3c: Renal tumor grossly extends into the vena cava above the diaphragm | |
| 369894003 | T4: Renal tumor invades beyond Gerota fascia | |
| 369895002 | T1: Breast tumor <= 2 cm in greatest dimension | |
| 369896001 | T1mic: Microinvasion <= 0.1 cm in greatest dimension: BREAST: Complete excision less than total mastectomy, total mastectomy, modified radical mastectomy, radical mastectomy | |
| 369897005 | T1a: Breast tumor >0.1 cm but <= 0.5 cm in greatest dimension | |
| 369898000 | T1b: Breast tumor >0.5 cm but <= 1 cm in greatest dimension | |
| 369899008 | T1c: >1 cm but <= 2 cm in greatest dimension: BREAST: Complete excision less than total mastectomy, total mastectomy, modified radical mastectomy, radical mastectomy | |
| 369900003 | T2: Breast tumor > 2 cm but <= 5 cm in greatest dimension | |
| 369901004 | T3: Breast tumor >5 cm in greatest dimension | |
| 369902006 | T4: Breast tumor of any size with direct extension to chest wall or skin | |
| 369903001 | T4a: Breast tumor with extension to chest wall | |
| 369904007 | T4b: Edema (including peau d'orange) or ulceration of the skin of the breast or satellite skin nodules confined to the same breast | |
| 369905008 | T4c: Breast tumor, both T4a and T4b | |
| 369906009 | T4d: Inflammatory carcinoma (breast) | |
| 369907000 | Tis: Carcinoma in situ, breast: Intraductal carcinoma, lobular carcinoma in situ, or Paget disease of the nipple with no tumor | |
| 369909002 | T1: Tumor invades lamina propria or submucosa | |
| 369910007 | T1a: Esophagus/stomach tumor invades lamina propria | |
| 369911006 | T1b: Esophagus/stomach tumor invades submucosa | |
| 369912004 | T2: Tumor invades muscularis propria | |
| 369913009 | T3: Esophageal tumor invades adventitia | |
| 369914003 | T4: Tumor directly invades adjacent structures | |
| 369915002 | T2: Stomach tumor invades muscularis propria or subserosa | |
| 369916001 | T2a: Stomach tumor invades muscularis propria | |
| 369917005 | T2b: Stomach tumor invades subserosa | |
| 369918000 | T3: Stomach tumor penetrates serosa without invasion of adjacent structures | |
| 369919008 | T4a: Colon/rectum tumor directly invades other organs or structures | |
| 369920002 | T1: Tumor invades submucosa (colon/rectum) | |
| 369921003 | T3: Colon/rectum tumor invades through the muscularis propria into the subserosa or the nonperitonealized pericolic or perirectal soft tissues | |
| 369922005 | T4b: Colon/rectum tumor penetrates the visceral peritoneum | |
| 369923000 | Tis (0): Carcinoma in situ (vagina) | |
| 369924006 | Tis (0): Carcinoma in situ (limited to fallopian tube mucosa) | |
| 369925007 | Tis: Epithelium only (carcinoma in situ, no invasion) | |
| 369926008 | T1: Tumor limited to ampulla of Vater or sphincter of Oddi | |
| 369927004 | T2: Ampulla tumor invades duodenal wall | |
| 369928009 | T3: Ampulla tumor invades 2 cm or less into pancreas | |
| 369929001 | T4: Ampulla tumor invades >2 cm into pancreas and/or into other adjacent organs | |
| 369930006 | T1: Tumor limited to pancreas and < 2 cm in greatest dimension | |
| 369931005 | T2: Tumor limited to pancreas and > 2 cm in greatest dimension | |
| 369932003 | T3: Pancreatic tumor extends directly to any of the following: duodenum; bile duct; peripancreatic tissues | |
| 369933008 | T4: Pancreas tumor extends directly to any of the following: stomach; spleen; colon; adjacent large vessels | |
| 369934002 | Tis: Carcinoma in situ ("flat tumor" of urinary bladder) | |
| 369935001 | T1: Urinary tract tumor invades subepithelial connective tissue | |
| 369936000 | T2: Urinary bladder tumor invades muscle | |
| 369937009 | T2: Renal pelvis/ureter tumor invades the muscularis | |
| 369938004 | T2a: Urinary bladder tumor invades superficial muscle (inner half) | |
| 369939007 | T2b: Urinary bladder tumor invades deep muscle (outer half) | |
| 369940009 | T3: Ureteral tumor invades beyond muscularis into periureteric fat | |
| 369941008 | T3: Renal pelvis tumor invades beyond muscularis peripelvic fat or the renal parenchyma | |
| 369942001 | T3: Urinary bladder tumor invades perivesical tissue | |
| 369943006 | T3a: Bladder tumor invades perivesical tissue microscopically | |
| 369944000 | T3b: Bladder tumor invades perivesical tissue macroscopically (extravesicular mass) | |
| 369945004 | T4: Urinary bladder tumor invades any of the following: prostate, uterus, vagina, pelvic wall abdominal wall | |
| 369946003 | T4: Renal pelvis/ureter tumor invades adjacent organs, or through the kidney into the perinephric fat | |
| 369947007 | T4a: Bladder tumor invades prostate or uterus or vagina | |
| 369948002 | T4b: Bladder tumor invades pelvic wall or abdominal wall | |
| 369949005 | Ta: Noninvasive papillary carcinoma (urinary tract) | |
| 369950005 | Tis: Intratubular germ cell neoplasia (carcinoma in situ, testis) | |
| 369951009 | T1: Testicular tumor limited to the testis and epididymis without vascular/lymphatic invasion (tumor may invade tunica albuginea but not tunica vaginalis) | |
| 369952002 | T2: Testicular tumor limited to the testis and epididymis with vascular/lymphatic invasion or tumor extending through tunica albuginea with involvement of tunica vaginalis | |
| 369953007 | T3: Testicular tumor invades spermatic cord with or without vascular/lymphatic invasion | |
| 369954001 | T4: Testicular tumor invades scrotum with or without vascular/lymphatic invasion | |
| 369955000 | T1 (I): Trophoblastic disease confined to uterus | |
| 369956004 | T1 (IA): Trophoblastic disease confined to uterus with no risk factors | |
| 369957008 | T1 (IB): Trophoblastic disease confined to uterus with one risk factor | |
| 369958003 | T1 (IC): Trophoblastic disease confined to uterus with two risk factors | |
| 369959006 | T2 (II): Trophoblast: gestational trophoblastic tumor extends outside of the uterus but is limited to the genital structures (adnexa, vagina, broad ligament) | |
| 369960001 | T2 (IIA): Trophoblast: GTT involving genital structure without risk factors | |
| 369961002 | T2 (IIB): Trophoblast: gestational trophoblastic tumor extends outside of the uterus but limited to genital structures with one risk factor | |
| 369962009 | T2 (IIC): Trophoblast: gestational trophoblastic tumor extends outside of the uterus but limited to genital structures with two risk factors | |
| 369963004 | T1: Tumor limited to ipsilateral parietal and/or visceral pleura | |
| 369964005 | T2: Pleural tumor invades any of the following: ipsilateral lung, endothoracic fascia, diaphragm, or pericardium | |
| 369965006 | T3: Pleural tumor invades any of the following: ipsilateral chest wall muscle, ribs, or media-stinal organs or tissues | |
| 369966007 | T4: Pleural tumor directly extends to any of the following: contralateral pleura, contralateral lung, peritoneum, intra-abdominal organs, cervical tissues | |
| 369967003 | T1: Tumor size < 1 cm, limited to thyroid | |
| 369968008 | T2: Tumor > 1 cm but < 4 cm, limited to thyroid | |
| 369969000 | T3: Thyroid tumor > 4 cm, limited to thyroid | |
| 369970004 | T4: Thyroid tumor of any size extending beyond the thyroid capsule | |
| 369971000 | T1a (IA): Tumor limited to one ovary, capsule intact, no tumor on ovarian surface | |
| 369972007 | T1b (IB): Tumor limited to both ovaries: capsule intact, no tumor on ovarian surface | |
| 369973002 | T1c (IC): Tumor limited to one or both ovaries with any of the following: capsule ruptured, tumor on ovarian surface, malignant cells in ascites or peritoneal washings: OVARY: Resection | |
| 369974008 | T2: Ovarian tumor involves one or both ovaries with pelvic extension | |
| 369975009 | T2a (IIA): Ovarian tumor with extension and/or implants on uterus and/or tube(s) | |
| 369976005 | T3 and/or N1 (III): Ovarian tumor involves one or both ovaries with microscopically confirmed peritoneal metastasis outside the pelvis and/or regional lymph node metastasis | |
| 369977001 | T3b (IIIB): Tumor of uterine cervix extends to pelvic wall and/or causes hydronephrosis or nonfunctioning kidney | |
| 369978006 | T2: Tumor confined within the prostate | |
| 369979003 | T1: Aerodigestive tract tumor < 2 cm in greatest dimension without extraparenchymal extension | |
| 369980000 | Tis: Tumor invades lamina propria (gastrointestinal tumor) | |
| 369981001 | Tis: Tumor invades muscularis mucosae (colon/rectum) | |
| 369982008 | T1: Solitary liver tumor < 2 cm; no vascular invasion | |
| 369983003 | N1: Metastasis to movable ipsilateral axillary lymph node(s) | |
| 369984009 | N1a: Only micrometastasis, none > 0.2 cm in greatest dimension | |
| 369985005 | N1b: Metastasis to lymph node(s), any > 0.2 cm in greatest dimension | |
| 369986006 | N1bi: Metastasis in 1 to 3 lymph nodes, any > 0.2 cm and all < 2 cm in greatest dimension | |
| 369987002 | N1bii: Metastasis in 4 or more lymph nodes, any > 0.2 cm and all < 2 cm in greatest dimension | |
| 369988007 | N1biii: Extension of tumor beyond the capsule of a lymph node metastasis, < 2 cm in greatest dimension | |
| 369989004 | N1biv: Metastasis to a lymph node > 2 cm in greatest dimension | |
| 369990008 | Clinical axillary lymph node metastases - matted | |
| 369991007 | N3: Metastasis to ipsilateral internal mammary lymph node(s) | |
| 369992000 | N1: Metastasis in 1-3 lymph nodes | |
| 369993005 | N2: Metastasis in 4 or more lymph nodes | |
| 369994004 | N1a: 1-3 nodes involved | |
| 369995003 | N1b: 4-7 nodes involved | |
| 369996002 | N1c: >7 nodes involved | |
| 369997006 | N1: Metastasis in 1-6 perigastric lymph nodes | |
| 369998001 | N2: Metastasis in 7-15 perigastric lymph nodes | |
| 369999009 | N3: Metastasis in >15 perigastric lymph nodes | |
| 370000006 | N1: Metastasis in a single lymph node, < 2 cm in greatest dimension | |
| 370001005 | N1: Metastasis in a single lymph node, <= 2 cm in greatest dimension | |
| 370002003 | N2: Metastasis in a single lymph node, > 2 cm but <= 5 cm in greatest dimension, or multiple lymph nodes, none > 5 cm in greatest dimension | |
| 370003008 | N3: Metastasis in a lymph node > 5 cm in greatest dimension | |
| 370004002 | N1: Metastasis in a single ipsilateral lymph node, < 3 cm in greatest dimension | |
| 370005001 | N1: Unilateral metastasis in lymph node(s) > 6 cm in greatest dimension, above supraclavicular fossa | |
| 370006000 | N2: Metastasis in a single ipsilat lymph node >3cm but <6cm in greatest dimension; or in multiple ipsilat lymph nodes, none >6cm in greatest dimension; or in bilat or contralat lymph nodes, none >6cm in greatest dimension | |
| 370007009 | N2: Bilateral metastasis in lymph node(s) > 6 cm in greatest dimension, above supraclavicular fossa | |
| 370008004 | N2a: Metastasis in a single ipsilateral lymph node, > 3 cm but < 6 cm in greatest dimension | |
| 370009007 | N2b: Metastasis in multiple ipsilateral lymph nodes, none > 6 cm in greatest dimension | |
| 370010002 | N2c: Metastasis in bilateral or contralateral lymph nodes, none > 6 cm in greatest dimension | |
| 370011003 | N3: Metastasis in lymph node(s) | |
| 370012005 | N3a: > 6 cm in dimension | |
| 370013000 | N3b: extension to supraclavicular fossa | |
| 370014006 | N3: Metastasis in a lymph node > 6 cm in greatest dimension | |
| 370015007 | N1: Metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph nodes, including intrapulmonary nodes involved by direct extension of the primary tumor | |
| 370016008 | N2: Metastasis in ipsilateral mediastinal and/or subcarinal lymph node(s) | |
| 370017004 | N3: Metastasis in contralateral mediastinal, contralateral hilar, ipsilateral or contralateral scalene or supraclavicular lymph node(s) | |
| 370018009 | N1: Metastasis in a single lymph node | |
| 370019001 | N2: Metastasis in more than one regional lymph node | |
| 370020007 | N1: Metastasis with a lymph node mass less than 2 cm in greatest dimension and 5 or fewer positive nodes, none larger than 2 cm in greatest dimension | |
| 370021006 | N2: Metastasis with a lymph node mass >2 cm but <= 5 cm in greatest dimension, or more than 5 nodes positive, none > 5 cm; or evidence of extranodal extension of tumor | |
| 370022004 | N3: Metastasis with a lymph node mass > 5 cm in greatest dimension | |
| 370023009 | N1: Metastasis in regional lymph node or nodes | |
| 370024003 | N1: Pelvic or inguinal lymph node metastasis | |
| 370025002 | N1a: Metastasis in ipsilateral cervical lymph node(s) | |
| 370026001 | N1b: Metastasis in bilateral, midline, or contralateral cervical or mediastinal lymph node(s) | |
| 370027005 | N1a: Metastasis in single regional lymph node | |
| 370028000 | N1b: Metastasis in multiple regional lymph nodes | |
| 370029008 | M1 (IV): Distant metastasis | |
| 370030003 | M1 (IVB): Distant metastasis | |
| 370031004 | M1: Distant metastasis [includes metastasis to ipsilateral supraclavicular lymph nodes] | |
| 370032006 | M1: Distant metastasis, includes separate tumor nodule(s) in a different lobe (ipsilateral or contralateral) | |
| 370033001 | M1a: Non-regional lymph node or pulmonary metastasis | |
| 370034007 | M1a: non-regional lymph node metastasis | |
| 370035008 | M1a (III): gestational trophoblastic tumor extends to the lungs with or without genital tract involvement | |
| 370036009 | M1a (IIIA): gestational trophoblastic tumor extends to the lungs with or without genital tract involvement without risk factors | |
| 370037000 | M1a (IIIB): gestational trophoblastic tumor extends to the lungs with or without genital tract involvement with one risk factor | |
| 370038005 | M1a (IIIC): gestational trophoblastic tumor extends to the lungs with or without genital tract involvement with two risk factors | |
| 370039002 | M1b (IV): All other metastatic sites | |
| 370040000 | M1b (IVA): All other metastatic sites without risk factors | |
| 370041001 | M1b (IVB): All other metastatic sites with one risk factor | |
| 370042008 | M1b (IVC): All other metastatic sites with two risk factors | |
| 370043003 | M1b: Bone(s) | |
| 370044009 | M1b: Distant metastasis other than to non-regional lymph nodes and lungs | |
| 370045005 | M1c: Other site(s) | |
| 370046006 | T3a,b: Colon/rectum tumor invades <=5 mm beyond the border of the muscularis propria | |
| 370047002 | T3c,d: Colon/rectum tumor invades >5 mm beyond the border of the muscularis propria | |
| 370072002 | Direct invasion of adrenal (T3a) | |
| 370123006 | N1: Regional lymph node metastasis | |
| 372436009 | N1: Metastasis in perirectal lymph node or nodes | |
| 372437000 | N2: Metastasis to unilateral internal iliac and/or inguinal lymph node(s) | |
| 373150000 | pNX: Regional lymph nodes cannot be assessed (e.g., previously removed, or not removed for pathologic study) (breast) | |
| 373151001 | pN0: No regional lymph node metastasis histologically (i.e., none greater than 0.2 mm), no additional examination for isolated tumor cells (breast) | |
| 373156006 | pN1: Metastasis in 1 to 3 axillary lymph nodes, and/or in internal mammary nodes with microscopic disease detected by sentinel lymph node dissection but not clinically apparent (breast) | |
| 373157002 | pN1mi: Micrometastasis (greater than 0.2 mm, none greater than 2.0 mm) (breast) | |
| 373158007 | pN1mi(i+): Micrometastasis detected only by IHC (breast) | |
| 373159004 | pN1a: Metastasis in 1 to 3 axillary lymph nodes (breast) | |
| 373160009 | pN1b: Metastasis in internal mammary lymph nodes with microscopic disease detected by sentinel lymph node dissection but not clinically apparent (breast) | |
| 373161008 | pN1c: Metastasis in 1 to 3 axillary lymph nodes and in internal mammary lymph nodes with microscopic disease detected by sentinel lymph node dissection but not clinically apparent (breast) | |
| 373162001 | pN2: Metastasis in 4 to 9 axillary lymph nodes, or in clinically apparent internal mammary lymph nodes in the absence of axillary lymph node metastasis (breast) | |
| 373163006 | pN2a: Metastasis in 4 to 9 axillary lymph nodes (at least one tumor deposit greater than 2.0 mm) (breast) | |
| 373164000 | pN2b: Metastasis in clinically apparent internal mammary lymph nodes in the absence of axillary lymph node metastasis (breast) | |
| 373165004 | pN3a: Metastasis in 10 or more axillary lymph nodes (at least one tumor deposit greater than 2.0 mm), or metastasis to infraclavicular lymph nodes (breast) | |
| 373166003 | pN3c: Metastasis in ipsilateral supraclavicular lymph nodes (breast) | |
| 373167007 | pN3b: Tumor of breast with metastasis as per AJCC 6th Edition definition (breast) | |
| 373169005 | pM0: No distant metastasis from breast tumor | |
| 373170006 | pMX: Distant metastasis cannot be assessed (breast) | |
| 373171005 | pM1: Distant metastasis (breast) | |
| 373172003 | pT1: Tumor 2 cm or less in greatest dimension (breast) | |
| 373173008 | pTX: Primary tumor cannot be assessed (breast) | |
| 373174002 | pT0: No evidence of primary tumor (breast) | |
| 373175001 | pTis: Carcinoma in situ (breast) | |
| 373176000 | pTis: Ductal carcinoma in situ (breast) | |
| 373177009 | pTis: Lobular carcinoma in situ (breast) | |
| 373178004 | pTis: Paget's disease of the nipple with no tumor | |
| 373179007 | pT1mic: Microinvasion <= 0.1 cm in greatest dimension (breast) | |
| 373180005 | pT1a: Tumor >0.1 cm but <= 0.5 cm in greatest dimension (breast) | |
| 373182002 | pT2: Tumor > 2 cm but <= 5 cm in greatest dimension (breast) | |
| 373183007 | pT1c: Tumor more than 1 cm but not more than 2 cm in greatest dimension (breast) | |
| 373184001 | pT3: Tumor >5 cm in greatest dimension (breast) | |
| 373185000 | pT4: Tumor of any size with direct extension to chest wall or skin (breast) | |
| 373186004 | pT4a: Tumor of any size with extension to chest wall, not including pectoralis muscle (breast) | |
| 373187008 | pT4b: Tumor of any size with edema (including peau d'orange) or ulceration of the skin of the breast or satellite skin nodules confined to the same breast | |
| 373189006 | pT4c: Tumor of any size with direct extension to chest wall (not including pectoralis muscle) and edema (including peau d'orange) or ulceration of the skin of the breast or satellite skin nodules confined to the same breast | |
| 373190002 | pT4d: Inflammatory carcinoma (breast) | |
| 373199001 | pTis: Tumor invades muscularis mucosae (colon/rectum) | |
| 373200003 | pT1: Tumor invades submucosa (colon/rectum) | |
| 373201004 | pTis: Tumor invades lamina propria (colon/rectum) | |
| 373204007 | pT1b: Tumor >0.5 cm but <= 1 cm in greatest dimension (breast) | |
| 384612007 | pT4a: Tumor directly invades other organs or structures (colon/rectum) | |
| 384613002 | pT4b: Tumor penetrates visceral peritoneum (colon/rectum) | |
| 384748000 | pM1: Distant metastasis, includes separate tumor nodule(s) in a different lobe (ipsilateral or contralateral) (lung) | |
| 384749008 | pN1: Metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph nodes, including intrapulmonary nodes involved by direct extension of the primary tumor (lung) | |
| 384750008 | pN2: Metastasis to ipsilateral mediastinal and/or subcarinal lymph nodes(s) (lung) | |
| 384751007 | pN3: Metastasis to contralateral mediastinal, contralateral hilar, ipsilateral or contralateral scalene, or supraclavicular lymph nodes(s) (lung) | |
| 384753005 | pT1: Tumor 3 cm or less in greatest dimension, surrounded by lung or visceral pleura, without bronchoscopic evidence of invasion more proximal than the lobar bronchus (i.e., not in the main bronchus) (lung) | |
| 384754004 | pT2: Tumor of lung as per AJCC 6th Edition definition (lung) | |
| 384755003 | pT3:Tumor directly invades any of following:chest wall,diaphragm,mediastinal pleura,parietal pericardium;or tumor in main bronchus<2 cm distal to carina(not involving it);or assoc atelectasis or obstructive pneumonitis of whole lung | |
| 384756002 | pT4: Tumor of lung as per AJCC 6th Edition definition (lung) | |
| 384757006 | pTX: Primary tumor cannot be assessed, or tumor proven by the presence of malignant cells in sputum or bronchial washings but not visualized by imaging or bronchoscopy (lung) | |
| 384983005 | pT2: Organ confined (prostate) | |
| 384984004 | pT2a: Unilateral, one-half of one lobe or less (prostate) | |
| 384985003 | pT2b: Unilateral, involving more than one-half of lobe but not both lobes (prostate) | |
| 384986002 | pT2c: Bilateral disease (prostate) | |
| 384987006 | pT3: Extraprostatic extension (prostate) | |
| 384988001 | pT3a: Extraprostatic extension (prostate) | |
| 384989009 | pT3b: Seminal vesicle invasion (prostate) | |
| 384990000 | pT4: Invasion of bladder AND/OR rectum (prostate) | |
| 385301007 | pT1: Tumor 2 cm or less in greatest dimension (anal canal) | |
| 385302000 | pT2: Tumor more than 2 cm but not more than 5 cm in greatest dimension (anal canal) | |
| 385303005 | pT3: Tumor more than 5 cm in greatest dimension (anal canal) | |
| 385304004 | pT4: Tumor of any size invades adjacent organ(s), e.g., vagina, urethra, bladder (anal canal) | |
| 385306002 | pN1: Metastasis in perirectal lymph node(s) (anal canal) | |
| 385307006 | pN2: Metastasis in unilateral internal iliac AND/OR inguinal lymph node(s) (anal canal) | |
| 385308001 | pN3: Metastasis in perirectal and inguinal lymph nodes AND/OR bilateral internal iliac AND/OR inguinal lymph nodes (anal canal) | |
| 385316005 | pT1: Tumor invades lamina propria or submucosa (stomach) | |
| 385317001 | pT1a: Tumor invades lamina propria (stomach) | |
| 385318006 | pT1b: Tumor invades submucosa (stomach) | |
| 385319003 | pT2: Tumor invades muscularis propria or subserosa (stomach) | |
| 385320009 | pT2a: Tumor invades muscularis propria (stomach) | |
| 385321008 | pT2b: Tumor invades subserosa (stomach) | |
| 385322001 | pT3: Tumor penetrates serosa (visceral peritoneum) without invasion of adjacent structures (stomach) | |
| 385323006 | pT4: Tumor invades adjacent structures (stomach) | |
| 385324000 | pN1: Metastasis in 1 to 6 regional (perigastric) lymph nodes (stomach) | |
| 385325004 | pN2: Metastasis in 7 to 15 regional (perigastric) lymph nodes (stomach) | |
| 385326003 | pN3: Metastasis in more than 15 regional (perigastric) lymph nodes (stomach) | |
| 385358008 | Dukes stage finding | |
| 385360005 | Modified Dukes stage finding | |
| 385362002 | FIGO stage finding for gynecological malignancy | |
| 385364001 | FIGO ovarian tumor stage finding | |
| 385366004 | FIGO stage finding for epithelial tumor of ovary | |
| 385368003 | FIGO stage finding for cervical carcinoma | |
| 385370007 | FIGO stage finding for vulvar carcinoma | |
| 385372004 | FIGO stage finding for vulvar melanoma | |
| 385374003 | FIGO uterine tumor stage finding | |
| 385376001 | FIGO stage finding for endometrial carcinoma | |
| 385378000 | pM category finding | |
| 385379008 | TNM tumor staging finding | |
| 385380006 | Metastasis stage finding | |
| 385381005 | pN category finding | |
| 385382003 | Node stage finding | |
| 385385001 | pT category finding | |
| 385389007 | Lymphoma stage finding | |
| 385392006 | Colon/rectum TNM finding | |
| 385415005 | Anal canal TNM finding | |
| 385416006 | Prostate TNM finding | |
| 385417002 | Breast TNM finding | |
| 385418007 | Lung TNM finding | |
| 394939004 | Dukes stage A | |
| 394940002 | Dukes stage B | |
| 394941003 | Dukes stage C1 | |
| 394942005 | Dukes stage C2 | |
| 394943000 | Dukes stage D | |
| 395705003 | pTis: Carcinoma in situ, intraepithelial (colon/rectum) | |
| 395706002 | pT2: Tumor invades muscularis propria (colon/rectum) | |
| 395707006 | pT3: Tumor invades through the muscularis propria into the subserosa or into non-peritonealized pericolic or perirectal tissues (colon/rectum) | |
| 395708001 | pT3a,b: Tumor invades through the muscularis propria into the subserosa or into non-peritonealized pericolic or perirectal tissues, invades 5 mm or less beyond the border of the muscularis propria (colon/rectum) | |
| 395709009 | pT3c,d: Tumor invades through the muscularis propria into the subserosa or into non-peritonealized pericolic or perirectal tissues, invades greater than 5 mm beyond the border of the muscularis propria (colon/rectum) | |
| 395710004 | pT4: Tumor directly invades other organs or structures and/or perforates visceral peritoneum (colon/rectum) | |
| 395711000 | pN1: Metastasis in 1 to 3 regional lymph nodes (colon/rectum) | |
| 395712007 | pN2: Metastasis in 4 or more regional lymph nodes (colon/rectum) | |
| 396082002 | pT1: Tumor 7 cm or less in greatest dimension, limited to the kidney (kidney) | |
| 396083007 | Kidney TNM finding | |
| 396084001 | pT1a: Tumor 4 cm or less in greatest dimension, limited to the kidney (kidney) | |
| 396085000 | pT1b: Tumor more than 4 cm but not more than 7 cm in greatest dimension, limited to the kidney (kidney) | |
| 396086004 | pT2: Tumor more than 7 cm in greatest dimension, limited to the kidney (kidney) | |
| 396087008 | pT3: Tumor extends into major veins or invades adrenal gland or perirenal and/or renal sinus fat but not beyond Gerota's fascia (kidney) | |
| 396088003 | pT3a: Tumor directly invades adrenal gland or perirenal and/or renal sinus fat but not beyond Gerota's fascia (kidney) | |
| 396089006 | pT3b: Tumor grossly extends into the renal vein or its segmental (muscle-containing) branches, or vena cava below the diaphragm (kidney) | |
| 396090002 | pT3c: Tumor grossly extends into vena cava above diaphragm or invades the wall of the vena cava (kidney) | |
| 396091003 | pT4: Tumor invades beyond Gerota's fascia (kidney) | |
| 396092005 | pN1: Metastasis in a single regional lymph node (kidney) | |
| 396093000 | pN2: Metastasis in more than one regional lymph node (kidney) | |
| 396094006 | Ampulla of Vater TNM finding | |
| 396095007 | pT1: Tumor limited to ampulla of Vater or sphincter of Oddi (ampulla of Vater) | |
| 396096008 | pT2: Tumor invades duodenal wall (ampulla of Vater) | |
| 396097004 | pT3: Tumor invades pancreas (ampulla of Vater) | |
| 396098009 | pT4: Tumor invades peripancreatic soft tissues or other adjacent organs or structures (ampulla of Vater) | |
| 396099001 | Liver TNM finding | |
| 396100009 | pT1: Solitary tumor without vascular invasion (liver, including intrahepatic bile ducts) | |
| 396101008 | pT2: Solitary tumor with vascular invasion or multiple tumors none more than 5 cm (liver, including intrahepatic bile ducts) | |
| 396102001 | pT3: Multiple tumors more than 5 cm or tumor involving a major branch of the portal or hepatic vein(s) (liver, including intrahepatic bile ducts) | |
| 396103006 | pT4: Tumor(s) with direct invasion of adjacent organs other than the gallbladder or with perforation of visceral peritoneum (liver, including intrahepatic bile ducts) | |
| 396282005 | Uterine cervix TNM finding | |
| 396283000 | pT1 (I): Cervical carcinoma confined to uterus (extension to corpus should be disregarded) (TNM category and FIGO stage) (uterine cervix) | |
| 396287004 | pT1a (IA): Invasive carcinoma diagnosed only by microscopy. All macroscopically visible lesions (even with superficial invasion) are pT1b/IB (TNM category and FIGO stage) (uterine cervix) | |
| 396288009 | pT1a1 (IA1): Measured stromal invasion 3.0 mm or less in depth and 7.0 mm or less in horizontal spread (TNM category and FIGO stage) (uterine cervix) | |
| 396289001 | pT1a2 (IA2): Measured stromal invasion more than 3.0 mm and not more than 5.0 mm in depth and 7.0 mm or less horizontal spread (TNM category and FIGO stage) (uterine cervix) | |
| 396290005 | pT1b (IB): Clinically visible lesion confined to the cervix or microscopic lesion greater than T1a2/IA2 (TNM category and FIGO stage) (uterine cervix) | |
| 396291009 | pT1b1 (IB1): Clinically visible lesion 4.0 cm or less in greatest dimension (TNM category and FIGO stage) (uterine cervix) | |
| 396292002 | pT1b2 (IB2): Clinically visible lesion more than 4.0 cm in greatest dimension (TNM category and FIGO stage) (uterine cervix) | |
| 396294001 | pT2 (II): Cervical carcinoma invades beyond uterus but not to pelvic wall or to lower third of vagina (TNM category and FIGO stage) (uterine cervix) | |
| 396297008 | pT2a (IIA): Tumor without parametrial invasion (TNM category and FIGO stage) (uterine cervix) | |
| 396298003 | pT2b (IIB): Tumor with parametrial invasion (TNM category and FIGO stage) (uterine cervix) | |
| 396299006 | pT3 (III): Tumor extends to pelvic wall and/or involves lower third of vagina and/or causes hydronephrosis or non-functioning kidney (TNM category and FIGO stage) (uterine cervix) | |
| 396300003 | pT3a (IIIA): Tumor involves lower third of vagina, no extension to pelvic wall (TNM category and FIGO stage) (uterine cervix) | |
| 396301004 | pT3b (IIIB): Tumor extends to pelvic wall and/or causes hydronephrosis or non-functioning kidney (TNM category and FIGO stage) (uterine cervix) | |
| 396302006 | pT4 (IVA): Tumor invades mucosa of bladder or rectum and/or extends beyond true pelvis (bullous edema is not sufficient evidence to classify a tumor as pT4) (TNM category and FIGO stage) (uterine cervix) | |
| 396303001 | pM1 (IVB): Distant metastasis (TNM category and FIGO stage) (corpus uteri) | |
| 396311006 | Corpus uteri TNM finding | |
| 396312004 | pT1 (I): Tumor confined to corpus uteri (TNM category and FIGO stage) (corpus uteri) | |
| 396313009 | pT1a (IA): Tumor limited to endometrium (TNM category and FIGO stage) (corpus uteri) | |
| 396314003 | pT1b (IB): Tumor invades less than one-half of the myometrium (TNM category and FIGO stage) (corpus uteri) | |
| 396315002 | pT1c (IC): Tumor invades one-half or more of the myometrium (TNM category and FIGO stage) (corpus uteri) | |
| 396316001 | pT2 (II): Tumor invades cervix but does not extend beyond uterus (TNM category and FIGO stage) (corpus uteri) | |
| 396317005 | pT2a (IIA): Tumor limited to the glandular epithelium of the endocervix. There is no evidence of connective tissue stromal invasion (TNM category and FIGO stage) (corpus uteri) | |
| 396318000 | pT2b (IIB): Invasion of the stromal connective tissue of the cervix (TNM category and FIGO stage) (corpus uteri) | |
| 396319008 | pT3 (III): Local and/or regional spread as specified in pT3a, pT3b, pN1, and FIGO IIIA, IIIB, and IIIC (TNM category and FIGO stage) (corpus uteri) | |
| 396320002 | pT3a (IIIA): Tumor involves serosa, AND/OR adnexa (direct extension or metastasis) AND/OR cancer cells in ascites or peritoneal washings (TNM category and FIGO stage) (corpus uteri) | |
| 396321003 | pT3b (IIIB): Involvement of vagina (direct extension or metastasis), rectal or bladder wall (without mucosal involvement), or pelvic wall(s) (frozen pelvis) (TNM category and FIGO stage) (corpus uteri) | |
| 396322005 | pT4 (IVA): Tumor invades bladder mucosa and/or bowel mucosa (TNM category and FIGO stage) (corpus uteri) | |
| 396323000 | pN1 (IIIC): Regional lymph node metastasis (TNM category and FIGO stage) (corpus uteri) | |
| 396368008 | Skin melanoma TNM finding | |
| 396369000 | pTis: Melanoma in situ (melanoma of the skin) | |
| 396370004 | pT1: Melanoma 1.0 mm or less in thickness, with or without ulceration (melanoma of the skin) | |
| 396371000 | pT1a: Melanoma 1.0 mm or less in thickness and level II or III, no ulceration (melanoma of the skin) | |
| 396372007 | pT1b: Melanoma 1.0 mm or less in thickness and level IV or V or with ulceration (melanoma of the skin) | |
| 396373002 | pT2: Melanoma 1.01 to 2.0 mm in thickness, with or without ulceration (melanoma of the skin) | |
| 396374008 | pT2a: Melanoma 1.01 to 2.0 mm in thickness, no ulceration (melanoma of the skin) | |
| 396375009 | pT2b: Melanoma 1.01 to 2.0 mm in thickness, with ulceration (melanoma of the skin) | |
| 396376005 | pT3: Melanoma 2.01 to 4.0 mm in thickness, with or without ulceration (melanoma of the skin) | |
| 396377001 | pT3a: Melanoma 2.01 to 4.0 mm in thickness, no ulceration (melanoma of the skin) | |
| 396378006 | pT3b: Melanoma 2.01 to 4.0 mm in thickness, with ulceration (melanoma of the skin) | |
| 396379003 | pT4: Melanoma greater than 4.0 mm in thickness, with or without ulceration (melanoma of the skin) | |
| 396380000 | pT4a: Melanoma greater than 4.0 mm in thickness, no ulceration (melanoma of the skin) | |
| 396381001 | pT4b: Melanoma greater than 4.0 mm in thickness, with ulceration (melanoma of the skin) | |
| 396382008 | pN1: Metastasis in one regional lymph node (melanoma of the skin) | |
| 396383003 | pN1a: Clinically occult (microscopic) metastasis (melanoma of the skin) | |
| 396384009 | pN1b: Clinically apparent (macroscopic) metastasis (melanoma of the skin) | |
| 396385005 | pN2: Metastasis in 2 to 3 regional nodes or intralymphatic regional metastasis without nodal metastasis (melanoma of the skin) | |
| 396386006 | pN2a: Clinically occult (microscopic) metastasis (melanoma of the skin) | |
| 396387002 | pN2b: Clinically apparent (macroscopic) metastasis (melanoma of the skin) | |
| 396388007 | pN2c: Satellite or in-transit metastasis without nodal metastasis (melanoma of the skin) | |
| 396389004 | pN3: Metastasis in four or more regional nodes, or matted metastatic nodes, or in-transit metastasis or satellite(s) with metastasis in regional node(s) (melanoma of the skin) | |
| 396390008 | pM1a: Metastasis to skin, subcutaneous tissues, or distant lymph nodes (melanoma of the skin) | |
| 396391007 | pM1b: Metastasis to lung (melanoma of the skin) | |
| 396392000 | pM1c: Metastasis to visceral site other than lung or distant metastasis at any site associated with an elevated serum lactic dehydrogenase (LDH) (melanoma of the skin) | |
| 396492004 | Carcinoma of skin (excluding eyelid, vulva, penis, and melanomas) TNM finding | |
| 396493009 | pT1: Tumor 2 cm or less in greatest dimension (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) | |
| 396494003 | pT1a: Tumor 2 cm or less in greatest dimension, limited to dermis or 2 mm or less in thickness (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) | |
| 396495002 | pT1b: Tumor 2 cm or less in greatest dimension, limited to dermis and greater than 2 mm in thickness, but not more than 6 mm in thickness (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) | |
| 396496001 | pT1c: Tumor 2 cm or less in greatest dimension, invading the subcutis and/or greater than 6 mm in thickness (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) | |
| 396497005 | pT2: Tumor more than 2 cm, but not more than 5 cm, in greatest dimension (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) | |
| 396498000 | pT2a: Tumor more than 2 cm, but not more than 5 cm, in greatest dimension, limited to dermis or greater than 2 mm in thickness (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) | |
| 396499008 | pT2b: Tumor more than 2 cm, but not more than 5 cm, in greatest dimension, limited to dermis and greater than 2 mm in thickness, but not more than 6 mm in thickness (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) | |
| 396500004 | pT2c: Tumor more than 2 cm, but not more than 5 cm, in greatest dimension, invading the subcutis and/or greater than 6 mm in thickness (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) | |
| 396501000 | pT3: Tumor more than 5 cm in greatest dimension (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) | |
| 396502007 | pT3a: Tumor more than 5 cm in greatest dimension, limited to dermis or not more than 2 mm in thickness (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) | |
| 396503002 | pT3b: Tumor more than 5 cm in greatest dimension, limited to dermis and greater than 2 mm in thickness, but not more than 6 mm in thickness (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) | |
| 396504008 | pT3c: Tumor more than 5 cm in greatest dimension, invading the subcutis and/or greater than 6 mm in thickness (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) | |
| 396506005 | pT4: Tumor invades deep extradermal structures (i.e. cartilage, skeletal muscle, or bone) (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) | |
| 396507001 | pT4b: Tumor invades deep extradermal structures (i.e. cartilage, skeletal muscle, or bone) greater than 6mm in thickness (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) | |
| 396508006 | pT4a: Tumor invades deep extradermal structures (i.e. cartilage, skeletal muscle, or bone) not more than 6mm in thickness (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) | |
| 396532004 | Stage I: Tumor confined to gland, 5 cm or less (adrenal cortical carcinoma) | |
| 396533009 | Stage II: Tumor confined to gland, greater than 5 cm (adrenal cortical carcinoma) | |
| 396534003 | Stage III: Extraglandular extension of tumor without other organ involvement (adrenal cortical carcinoma) | |
| 396535002 | Stage IV: Distant metastasis or extension into other organs (adrenal cortical carcinoma) | |
| 396566008 | Oropharynx TNM finding | |
| 396567004 | pT1: Tumor 2 cm or less in greatest dimension (oropharynx) | |
| 396568009 | Upper aerodigestive tract TNM finding | |
| 396569001 | pT2: Tumor more than 2 cm but not more than 4 cm in greatest dimension (oropharynx) | |
| 396570000 | pT3: Tumor more than 4 cm in greatest dimension (oropharynx) | |
| 396571001 | pT4a: Tumor invades the larynx, deep/extrinsic muscle of tongue, medial pterygoid muscle, hard palate, or mandible (oropharynx) | |
| 396572008 | pT4b: Tumor invades lateral pterygoid muscle, pterygoid plates, lateral nasopharynx, or skull base or encases carotid artery (oropharynx) | |
| 396573003 | Lip and oral cavity TNM finding | |
| 396574009 | pT2: Tumor more than 2 cm but not more than 4 cm in greatest dimension (lip and oral cavity) | |
| 396575005 | pT1: Tumor 2 cm or less in greatest dimension (lip and oral cavity) | |
| 396576006 | pT1: Tumor 2 cm or less in greatest dimension | |
| 396577002 | pT3: Tumor more than 4 cm in greatest dimension (lip and oral cavity) | |
| 396578007 | pT4a: Tumor invades through cortical bone, inferior alveolar nerve, floor of mouth, or skin of face, i.e., chin or nose (lip) | |
| 396579004 | pT4a: Tumor invades through cortical bone, into deep (extrinsic) muscle of tongue (genioglossus, hyoglossus, palatoglossus, and styloglossus), maxillary sinus, or skin of face (oral cavity) | |
| 396580001 | pT4b: Tumor involves masticator space, pterygoid plates, or skull base and/or encases internal carotid artery (lip and oral cavity) | |
| 396581002 | Hypopharyngeal TNM finding | |
| 396582009 | Nasopharynx TNM finding | |
| 396583004 | pT1: Tumor confined to the nasopharynx (nasopharynx) | |
| 396584005 | pT2a: Tumor extends to the soft tissues of the oropharnyx and/or nasal cavity without parapharyngeal extension (nasopharynx) | |
| 396585006 | pT2: Tumor extends to the soft tissues (nasopharynx) | |
| 396586007 | pT2b: Tumor extends to the soft tissues of the oropharnyx and/or nasal cavity with parapharyngeal extension (nasopharynx) | |
| 396587003 | pT3: Tumor involves bony structures and/or paranasal sinuses (nasopharynx) | |
| 396588008 | pT4: Tumor with intracranial extension, and/or involvement of cranial nerves, infratemporal fossa, hypopharynx, orbit, or masticator space (nasopharynx) | |
| 396589000 | pT1: Tumor limited to one subsite of hypopharynx and 2 cm or less in greatest dimension (hypopharynx) | |
| 396590009 | pT2: Tumor invades more than one subsite of hypopharynx or an adjacent site, or measures more than 2 cm but not more than 4 cm in greatest diameter without fixation of hemilarynx (hypopharynx) | |
| 396591008 | pT3: Tumor measures more than 4 cm in greatest dimension or with fixation of hemilarynx (hypopharynx) | |
| 396592001 | pT4a: Tumor invades thyroid/cricoid cartilage, hyoid bone, thyroid gland, esophagus or central compartment of soft tissue (hypopharynx) | |
| 396593006 | pT4b: Tumor invades prevertebral fascia, encases carotid artery, or involves mediastinal structures (hypopharynx) | |
| 396594000 | Supraglottis TNM finding | |
| 396595004 | pT1: Tumor limited to one subsite of supraglottis with normal vocal cord mobility (larynx, supraglottis) | |
| 396596003 | pT2: Tumor invades mucosa of more than one adjacent subsite of supraglottis or glottis or region outside the supraglottis (e.g., mucosa of base of tongue, vallecula, medial wall of pyriform sinus) without fixation of the larynx | |
| 396597007 | pT3: Tumor limited to the larynx with vocal cord fixation and/or invades any of the following: postcrocoid area, pre-epiglottic tissues, paraglottic space, and/or minor thyroid cartilage erosion (e.g., inner cortex) (larynx, supraglottis) | |
| 396598002 | pT4a: Tumor invades through the thyroid cartilage and/or invades tissues beyond the larynx (e.g., trachea, soft tissues of the neck including deep extrinsic muscle of the tongue, strap muscles, thyroid, or esophagus) (larynx, supraglottis) | |
| 396599005 | pT4b: Tumor invades prevertebral space, encases carotid artery, or invades mediastinal structures (larynx, supraglottis) | |
| 396600008 | Glottis TNM finding | |
| 396601007 | pT1: Tumor limited to the vocal cord(s) (may involve anterior or posterior commissure) with normal mobility (larynx, glottis) | |
| 396602000 | pT1a: Tumor limited to one vocal cord (may involve anterior or posterior commissure) with normal mobility (larynx, glottis) | |
| 396603005 | pT1b: Tumor involves both vocal cords (may involve anterior or posterior commissure) with normal mobility (larynx, glottis) | |
| 396604004 | pT2: Tumor extends to the supraglottis AND/OR subglottis, AND/OR with impaired vocal cord mobility (larynx, glottis) | |
| 396605003 | pT3: Tumor limited to the larynx with vocal cord fixation, and/or invades the paraglottic space, and/or minor thyroid cartilage erosion (larynx, glottis) | |
| 396606002 | pT4a: Tumor invades through thyroid cartilage and/or invades tissues beyond the larynx (e.g., trachea, soft tissues of the neck including deep intrinsic muscle of the tongue, strap muscles, thyroid, or esophagus) (larynx, glottis) | |
| 396607006 | pT4b: Tumor invades prevertebral space, encases carotid artery, or invades mediastinal structures (larynx, glottis) | |
| 396608001 | Subglottis TNM finding | |
| 396609009 | pT1: Tumor limited to the subglottis (larynx, subglottis) | |
| 396610004 | pT2: Tumor extends to vocal cord(s) with normal or impaired mobility (larynx, subglottis) | |
| 396611000 | pT3: Tumor limited to larynx with vocal cord fixation (larynx, subglottis) | |
| 396612007 | pT4a: Tumor invades cricoid or thyroid cartilage and/or invades tissues beyond the larynx (e.g., trachea, soft tissues of the neck including deep extrinsic muscle of the tongue, strap muscles, thyroid, or esophagus) (larynx, subglottis) | |
| 396613002 | pT4b: Tumor invades prevertebral space, encases carotid artery, or invades mediastinal structures (larynx, subglottis) | |
| 396614008 | Maxillary sinus TNM finding | |
| 396615009 | pT1: Tumor limited to the maxillary sinus mucosa with no erosion or destruction of bone (maxillary sinus) | |
| 396616005 | pT2: Tumor causing bone erosion or destruction including extension into the hard palate and/or middle nasal meatus, except extension to posterior wall of maxillary sinus and pterygoid plates (maxillary sinus) | |
| 396617001 | pT3: Tumor invades any of the following: bone of the posterior wall of maxillary sinus, subcutaneous tissues, floor or medial wall of orbit, pterygoid fossa, ethmoid sinuses (maxillary sinus) | |
| 396618006 | pT4a: Tumor invades anterior orbital contents, skin of cheek, pterygoid plates, infratemporal fossa, cribriform plate, sphenoid or frontal sinuses (maxillary sinus) | |
| 396619003 | pT4b: Tumor invades any of the following: orbital apex, dura, brain, middle cranial fossa, cranial nerves other than maxillary division of trigeminal nerve, nasopharynx, or clivus (maxillary sinus) | |
| 396621008 | Nasal cavity and ethmoid sinus TNM finding | |
| 396622001 | pT1: Tumor restricted to any one subsite, with or without bony invasion (nasal cavity and ethmoid sinus) | |
| 396623006 | pT2: Tumor invading two subsites in a single region or extending to involve an adjacent region within the nasoethmoidal complex, with or without bony invasion (nasal cavity and ethmoid sinus) | |
| 396624000 | pT3: Tumor extends to invade the medial wall or floor of the orbit, maxillary sinus, palate, or cribriform plate (nasal cavity and ethmoid sinus) | |
| 396625004 | pT4a: Tumor invades any of the following: anterior orbital contents, skin of nose or cheek, minimal extension to anterior cranial fossa, pterygoid plates, sphenoid or frontal sinuses (nasal cavity and ethmoid sinus) | |
| 396626003 | pT4b: Tumor invades any of the following: orbital apex, dura, brain, middle cranial fossa, cranial nerves other than maxillary division of trigeminal nerve, nasopharynx, or clivus (nasal cavity and ethmoid sinus) | |
| 396632008 | pN1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension (upper aerodigestive tract) | |
| 396633003 | pN2a: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 6 cm in greatest dimension (upper aerodigestive tract) | |
| 396634009 | pN2c: Metastasis in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension (upper aerodigestive tract) | |
| 396635005 | pN2b: Metastasis in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension (upper aerodigestive tract) | |
| 396636006 | pN3: Metastasis in a lymph node, more than 6 cm in greatest dimension (upper aerodigestive tract) | |
| 396637002 | pN1: Unilateral metastasis in lymph node(s), 6 cm or less in greatest dimension, above the supraclavicular fossa (nasopharynx) | |
| 396638007 | pN2: Bilateral metastasis in lymph node(s), 6 cm or less in greatest dimension, above the supraclavicular fossa (nasopharynx) | |
| 396639004 | pN3: Metastasis in a lymph node(s), more than 6 cm in dimension, and/or to supraclavicular fossa (nasopharynx) | |
| 396640002 | pN3a: Metastasis in a lymph node(s), more than 6 cm in dimension (nasopharynx) | |
| 396641003 | pN3b: Metastasis in lymph node(s) residing wholly or in part in the supraclavicular fossa (nasopharynx) | |
| 396648009 | Major salivary gland TNM finding | |
| 396650001 | pT1: Tumor 2 cm or less in greatest dimension without extraparenchymal extension (major salivary glands) | |
| 396651002 | pT2: Tumor more than 2 cm but not more than 4 cm in greatest dimension without extraparenchymal extension (major salivary glands) | |
| 396653004 | pT3: Tumor more than 4 cm and/or tumor having extraparenchymal extension (major salivary glands) | |
| 396657003 | pT4a: Tumor invades skin, mandible, ear canal, and/or facial nerve (major salivary glands) | |
| 396658008 | pT4b: Tumor invades skull base and/or pterygoid plates and/or encases carotid artery (major salivary glands) | |
| 396666004 | Urinary bladder, ureter, or renal pelvis TNM finding | |
| 396667008 | pTa: Non-invasive papillary carcinoma (urinary bladder, ureter, renal pelvis) | |
| 396668003 | pTis: Flat carcinoma in situ (urinary bladder, ureter, renal pelvis) | |
| 396669006 | pT1: Tumor invades subepithelial connective tissue (urinary bladder, ureter, renal pelvis) | |
| 396670007 | pT2: Tumor invades muscularis propria (urinary bladder, ureter, renal pelvis) | |
| 396671006 | pT2a: Tumor invades superficial muscle (inner half) (urinary bladder) | |
| 396672004 | pT2b: Tumor invades deep muscle (outer half) (urinary bladder) | |
| 396673009 | pT3: Tumor invades perivesical tissue (urinary bladder) | |
| 396674003 | pT3a: Tumor invades perivesical tissue microscopically (urinary bladder) | |
| 396675002 | pT3b: Tumor invades perivesical tissue macroscopically (extravesical mass) (urinary bladder) | |
| 396676001 | pT4: Tumor invades any of the following: prostate, uterus, vagina, pelvic wall, abdominal wall (urinary bladder) | |
| 396677005 | pT4a: Tumor invades prostate or uterus or vagina (urinary bladder) | |
| 396678000 | pT4b: Tumor invades pelvic wall or abdominal wall (urinary bladder) | |
| 396679008 | pN1: Metastasis in a single lymph node, 2 cm or less in greatest dimension (urinary bladder, ureter, renal pelvis) | |
| 396680006 | pN2: Metastasis in a single lymph node, more than 2 cm but not more than 5 cm in greatest dimension; or multiple lymph nodes, none more than 5 cm in greatest dimension (urinary bladder, ureter, renal pelvis) | |
| 396681005 | pT3: Tumor invades beyond muscularis into periureteric fat or renal parenchyma (renal pelvis) | |
| 396682003 | pT4: Tumor invades adjacent organs, or through the kidney into the perinephric fat (renal pelvis and ureter) | |
| 396683008 | pT3: Tumor invades beyond muscularis into periureteric fat (ureter) | |
| 396684002 | pT2: Tumor invades muscularis (renal pelvis and ureter) | |
| 396726006 | Testis TNM finding | |
| 396727002 | pTis: Intratubular germ cell neoplasia (carcinoma in situ) (testis) | |
| 396728007 | pT1: Tumor limited to the testis and epididymis without vascular/lymphatic invasion; tumor may invade into the tunica albuginea but not the tunica vaginalis (testis) | |
| 396729004 | pT2: Tumor limited to the testis and epididymis with vascular/lymphatic invasion, or tumor extending through the tunica albuginea with involvement of the tunica vaginalis (testis) | |
| 396730009 | pT3: Tumor invades the spermatic cord with or without vascular/lymphatic invasion (testis) | |
| 396731008 | pT4: Tumor invades the scrotum with or without vascular/lymphatic invasion (testis) | |
| 396732001 | pN1: Metastasis with a lymph node mass 2 cm or less in greatest dimension and less than or equal to 5 nodes positive, none more than 2 cm in greatest dimension (testis) | |
| 396733006 | pN2: Metastasis with a lymph node mass more than 2 cm but not more than 5 cm in greatest dimension; or more than 5 nodes positive, none more than 5 cm; or evidence of extranodal extension of tumor (testis) | |
| 396734000 | pN3: Metastasis with a lymph node mass more than 5 cm in greatest dimension (testis) | |
| 396735004 | pM1a: Non-regional nodal or pulmonary metastasis (testis) | |
| 396736003 | pM1b: Distant metastasis other than to non-regional lymph nodes and lungs (testis) | |
| 396797009 | Exocrine pancreas TNM finding | |
| 396798004 | pT1: Tumor limited to the pancreas, 2 cm or less in greatest dimension (exocrine pancreas) | |
| 396799007 | pT2: Tumor limited to the pancreas, more than 2 cm in greatest dimension (exocrine pancreas) | |
| 396800006 | pT3: Tumor extends beyond the pancreas but without involvement of the celiac axis or the superior mesenteric artery (exocrine pancreas) | |
| 396801005 | pN1a: Metastasis in single regional lymph node (exocrine pancreas) | |
| 396802003 | pN1b: Metastasis in multiple regional lymph node(s) (exocrine pancreas) | |
| 396803008 | pT4: Tumor involves the celiac axis or the superior mesenteric artery (exocrine pancreas) | |
| 396907008 | Thymic epithelial neoplasm stage finding | |
| 396908003 | Stage I: Grossly and microscopically encapsulated (thymus gland) | |
| 396909006 | Stage IIa: Microscopic transcapsular invasion (thymus gland) | |
| 396910001 | Stage IIb: Macroscopic capsular invasion into thymic or surrounding fat, or grossly adherent to, but not breaking through, mediastinal pleura or pericardium (thymus gland) | |
| 396911002 | Stage III: Macroscopic invasion of neighboring organs (thymus gland) | |
| 396912009 | Stage IVa: Pleural or pericardial dissemination (thymus gland) | |
| 396913004 | Stage IVb: Hematogenous or lymphatic dissemination (thymus gland) | |
| 396960007 | Retinoblastoma TNM finding | |
| 396961006 | pT1: Tumor confined to the retina, vitreous, or subretinal space. No optic nerve or choroidal invasion (retinoblastoma) | |
| 396962004 | pT2: Minimal invasion of the optic nerve and/or optic coats (retinoblastoma) | |
| 396963009 | pT2a: Tumor invades optic nerve up to, but not through, the level of the lamina cribrosa (retinoblastoma) | |
| 396964003 | pT2b: Tumor invades choroid focally (retinoblastoma) | |
| 396965002 | pT2c: Tumor invades optic nerve up to, but not through, the level of the lamina cribrosa and invades the choroid focally (retinoblastoma) | |
| 396966001 | pT3: Significant invasion of the optic nerve and/or optic coats (retinoblastoma) | |
| 396967005 | pT3a: Tumor invades optic nerve through the level of the lamina cribrosa but not to the line of resection (retinoblastoma) | |
| 396968000 | pT3b: Tumor massively invades the choroid (retinoblastoma) | |
| 396969008 | pT3c: Tumor invades the optic nerve through the level of the lamina cribrosa but not to the line of resection and massively invades the choroid (retinoblastoma) | |
| 396970009 | pT4: Extraocular tumor extension which includes sites as per AJCC 6th Edition definition (retinoblastoma) | |
| 396971008 | pM1a: Distant metastasis to bone marrow (retinoblastoma) | |
| 396972001 | pM1b: Distant metastasis to sites other than bone marrow (retinoblastoma) | |
| 397025005 | Stomach TNM finding | |
| 397026006 | pT1: Tumor invades lamina propria or submucosa (esophagus) | |
| 397027002 | Esophagus TNM finding | |
| 397029004 | pT1a: Tumor invades lamina propria (esophagus) | |
| 397030009 | pT1b: Tumor invades submucosa (esophagus) | |
| 397031008 | pT2: Tumor invades muscularis propria (esophagus) | |
| 397032001 | pT3: Tumor invades adventitia (esophagus) | |
| 397033006 | pT4: Tumor invades adjacent structures (esophagus) | |
| 397036003 | pN1a: Metastasis in 1 to 3 regional lymph nodes (esophagus) | |
| 397037007 | pN1b: Metastasis in 4 to 7 regional lymph nodes (esophagus) | |
| 397038002 | pN1c: Metastasis in more than 7 regional lymph nodes (esophagus) | |
| 397039005 | pM1a: Metastasis in celiac lymph nodes (lower thoracic esophagus) | |
| 397040007 | pM1a: Distant metastasis not applicable (midthoracic esophagus) | |
| 397041006 | pM1a: Metastasis in cervical nodes (upper thoracic esophagus) | |
| 397042004 | pM1b: Distant metastasis to site other than celiac lymph nodes (lower thoracic esophagus) | |
| 397043009 | pM1b: Nonregional lymph nodes AND/OR other distant metastasis (midthoracic esophagus) | |
| 397044003 | pM1b: Distant metastasis to site other than cervical nodes (upper thoracic esophagus) | |
| 397058001 | Small intestine TNM finding | |
| 397059009 | pT1: Tumor invades lamina propria or submucosa (small intestine) | |
| 397088005 | pT2: Tumor invades muscularis propria (small intestine) | |
| 397089002 | pT3: Tumor invades through the muscularis propria into the subserosa or into the nonperitonealized perimuscular tissue (mesentery or retroperitoneum) with extension 2 cm or less (small intestine) | |
| 397090006 | pT4: Tumor perforates the visceral peritoneum or directly invades other organs or structures (small intestine) | |
| 397092003 | Gallbladder TNM finding | |
| 397093008 | pT1: Tumor invades lamina propria or muscle layer (gallbladder) | |
| 397094002 | pT1a: Tumor invades lamina propria (gallbladder) | |
| 397095001 | pT1b: Tumor invades muscle layer (gallbladder) | |
| 397096000 | pT2: Tumor invades perimuscular connective tissue; no extension beyond serosa or into liver (gallbladder) | |
| 397097009 | pT3: Tumor perforates the serosa (visceral peritoneum) and/or directly invades the liver and/or one other adjacent organ or structure, such as the stomach, duodenum, colon, pancreas, omentum, or extrahepatic bile ducts (gallbladder) | |
| 397098004 | pT4: Tumor invades main portal vein or hepatic artery or invades two or more extrahepatic organs or structures (gallbladder) | |
| 397101000 | Vagina TNM finding | |
| 397102007 | pT1 (I): Tumor confined to vagina (TNM category and FIGO stage) (vagina) | |
| 397103002 | pT2 (II): Tumor invades paravaginal tissues but not to pelvic wall (TNM category and FIGO stage) (vagina) | |
| 397104008 | pT3 (III): Tumor extends to pelvic wall (TNM category and FIGO stage) (vagina) | |
| 397105009 | pT4 (IVA): Tumor invades mucosa of the bladder or rectum and/or extends beyond the true pelvis (bullous edema is not sufficient evidence to classify a tumor as T4) (TNM category and FIGO stage) (vagina) | |
| 397106005 | pM1 (IVB): Distant metastasis (TNM category and FIGO stage) (vagina) | |
| 397107001 | pN1: Pelvic or inguinal lymph node metastasis (vagina) | |
| 397119009 | Vulva TNM finding | |
| 397120003 | pT1 (I): Tumor confined to the vulva or vulva and perineum, 2 cm or less in greatest dimension (TNM category and FIGO stage) (vulva) | |
| 397121004 | pT1a (IA): Tumor confined to the vulva or vulva and perineum, 2 cm or less in greatest dimension, and with stromal invasion no greater than 1 mm (TNM category and FIGO stage) (vulva) | |
| 397122006 | pT1b (IB): Tumor confined to the vulva or vulva and perineum, 2 cm or less in greatest dimension, and with stromal invasion greater than 1 mm (TNM category and FIGO stage) (vulva) | |
| 397123001 | pT2 (II): Tumor confined to the vulva or vulva and perineum, more than 2 cm in greatest dimension (TNM category and FIGO stage) (vulva) | |
| 397124007 | pT3 (III): Tumor of any size with contiguous spread to the lower urethra and/or vagina or anus (TNM category and FIGO stage) (vulva) | |
| 397125008 | pT4 (IVA): Tumor invades any of the following: upper urethra, bladder mucosa, rectal mucosa, or is fixed to the pubic bone (TNM category and FIGO stage) (vulva) | |
| 397126009 | pN1: Unilateral regional lymph node metastasis (vulva) | |
| 397127000 | pN2: Bilateral regional lymph node metastasis (vulva) | |
| 397146004 | Extrahepatic bile ducts TNM finding | |
| 397147008 | pT1: Tumor confined to the bile duct histologically (extrahepatic bile ducts) | |
| 397148003 | pT2: Tumor invades beyond the wall of bile duct (extrahepatic bile ducts) | |
| 397149006 | pT3: Tumor invades the liver, gallbladder, pancreas, and/or ipsilateral branches of the portal vein (right or left) or hepatic artery (right or left) (extrahepatic bile ducts) | |
| 397150006 | pT4: Tumor invades any of the following: main portal vein or its branches bilaterally, common hepatic artery, or other adjacent structures, such as the colon, stomach, duodenum, or abdominal wall (extrahepatic bile ducts) | |
| 397213002 | pM1a: Distant metastasis to non-regional lymph node(s) (prostate) | |
| 397214008 | pM1b: Distant metastasis to bone(s) (prostate) | |
| 397215009 | pM1c: Distant metastasis site other than bone or non-regional lymph node(s) (prostate) | |
| 397316007 | Ovary TNM finding | |
| 397317003 | pM1 (IV): Distant metastasis (TNM category and FIGO stage) (ovary) | |
| 397360007 | pT3a (IIIA): Tumor involves serosa, AND/OR adnexa (direct extension or metastasis) (TNM category and FIGO stage) (corpus uteri) | |
| 397367005 | pN1 (III): Pelvic or inguinal lymph node metastasis (pT1-pT3) (TNM category and FIGO stage) (vagina) | |
| 397368000 | pN1 (IVA): Pelvic or inguinal lymph node metastasis (pT4) (TNM category and FIGO stage) (vagina) | |
| 397369008 | pN1 (IVB): Pelvic or inguinal lymph node metastasis (pT1-pT4, pM1) (TNM category and FIGO stage) (vagina) | |
| 397370009 | pN1 (III): Unilateral regional lymph node metastasis (pT1-pT3) (TNM category and FIGO stage) (vulva) | |
| 397371008 | pN1 (IVA): Unilateral regional lymph node metastasis (pT4) (TNM category and FIGO stage) (vulva) | |
| 397372001 | pN1 (IVB): Unilateral regional lymph node metastasis (pT1-pT4, pM1) (TNM category and FIGO stage) (vulva) | |
| 397373006 | pN2 (IVA): Bilateral regional lymph node metastasis (pT1-pT4) (TNM category and FIGO stage) (vulva) | |
| 397374000 | pN2 (IVB): Bilateral regional lymph node metastasis (pT1-pT4, pM1) (TNM category and FIGO stage) (vulva) | |
| 397375004 | pM1 (IVB): Distant metastasis (including pelvic lymph node metastasis) (TNM category and FIGO stage) (vulva) | |
| 397385003 | Thoracic mesothelioma TNM finding | |
| 397386002 | pT1: Tumor involves ipsilateral parietal pleura, with or without focal involvement of visceral pleura (thoracic mesothelioma) | |
| 397387006 | pT1a: Tumor involves ipsilateral parietal (mediastinal, diaphragmatic) pleura. No involvement of the visceral pleura (thoracic mesothelioma) | |
| 397388001 | pT1b: Tumor involves ipsilateral parietal (mediastinal, diaphragmatic) pleura, with focal involvement of the visceral pleura (thoracic mesothelioma) | |
| 397389009 | pT2: Tumor involves any of the ipsilateral pleural surfaces with at least one of the following: confluent visceral pleural tumor (including fissure), invasion of diaphragmatic muscle, invasion of lung parenchyma (thoracic mesothelioma) | |
| 397390000 | pN1: Metastasis in the ipsilateral bronchopulmonary and/or hilar lymph node(s) (thoracic mesothelioma) | |
| 397391001 | pN2: Metastasis in the subcarinal lymph node(s) and/or the ipsilateral internal mammary or mediastinal lymph node(s) (thoracic mesothelioma) | |
| 397392008 | pN3: Metastasis in the contralateral mediastinal, internal mammary, or hilar lymph node(s), and/or the ipsilateral or contralateral supraclavicular or scalene lymph node(s) (thoracic mesothelioma) | |
| 397393003 | pT3: Tumor involves any of the ipsilateral pleural surfaces plus additional sites as by AJCC 6th Edition definition (thoracic mesothelioma) | |
| 397465003 | pT4: Tumor involves any of the ipsilateral pleural surfaces plus additional sites as by AJCC 6th Edition definition (thoracic mesothelioma) | |
| 397470005 | Gestational trophoblast TNM finding | |
| 397471009 | pT1 (I): Tumor confined to uterus (TNM category and FIGO stage) (gestational trophoblast) | |
| 397472002 | pT2 (II): Tumor extends outside of uterus but limited to genital structures (ovary, tube, vagina, broad ligaments) (TNM category and FIGO stage) (gestational trophoblast) | |
| 397473007 | pM1a (III): Tumor extends to the lungs with or without genital tract involvement (TNM category and FIGO stage) (gestational trophoblast) | |
| 397474001 | pM1b (IV): Distant metastasis other than lung (TNM category and FIGO stage) (gestational trophoblast) | |
| 397489005 | pT1 (I): Tumor limited to ovaries (one or both) (TNM category and FIGO stage) (ovary) | |
| 397490001 | pT1a (IA): Tumor limited to one ovary; capsule intact, no tumor on ovarian surface. No malignant cells in ascites or peritoneal washings (TNM category and FIGO stage) (ovary) | |
| 397491002 | pT1b (IB): Tumor limited to both ovaries; capsule intact, no tumor on ovarian surface. No malignant cells in ascites or peritoneal washings (TNM category and FIGO stage) (ovary) | |
| 397492009 | pT1c (IC): Tumor limited to one or both ovaries with any of the following: capsule ruptured, tumor on ovarian surface, malignant cells in ascites or peritoneal washings (TNM category and FIGO stage) (ovary) | |
| 397493004 | pT2 (II): Tumor involves one or both ovaries with pelvic extension AND/OR implants (TNM category and FIGO stage) (ovary) | |
| 397494005 | pT2a (IIA): Extension to AND/OR implants on uterus AND/OR tube(s). No malignant cells in ascites or peritoneal washings (TNM category and FIGO stage) (ovary) | |
| 397495006 | pT2b (IIB): Extension to AND/OR implants on other pelvic tissues. No malignant cells in ascites or peritoneal washings (TNM category and FIGO stage) (ovary) | |
| 397496007 | pT2c (IIC): Pelvic extension AND/OR implants (T2a or T2b/IIA or IIB) with malignant cells in ascites or peritoneal washings (TNM category and FIGO stage) (ovary) | |
| 397497003 | pT3 and/or N1 (III): Tumor involves one or both ovaries with microscopically confirmed peritoneal metastasis outside the pelvis (including liver capsule metastasis) and/or regional lymph node metastasis (TNM category and FIGO stage) (ovary) | |
| 397498008 | pT3a (IIIA): Microscopic peritoneal metastasis beyond pelvis (no macroscopic tumor) (TNM category and FIGO stage) (ovary) | |
| 397499000 | pT3b (IIIB): Macroscopic peritoneal metastasis beyond pelvis 2 cm or less in greatest dimension (TNM category and FIGO stage) (ovary) | |
| 397500009 | pT3c AND/OR N1 (IIIC): Peritoneal metastasis beyond pelvis more than 2 cm in greatest dimension AND/OR regional lymph node metastasis (TNM category and FIGO stage) (ovary) | |
| 397501008 | Any T/any N and M1 (IV): Growth involving one or both ovaries with distant metastasis. (TNM category and FIGO stage) (ovary) | |
| 399378007 | pT2a (IIA): Tumor involves one or both fallopian tubes with extension and/or metastasis to the uterus and/or ovaries (TNM category and FIGO stage) (fallopian tube) | |
| 399393006 | pT3: Tumor more than 4 cm in greatest dimension limited to the thyroid or any tumor with minimal extrathyroid extension (e.g., extension to sternothyroid muscle or perithyroid soft tissues) (thyroid) | |
| 399397007 | pT2: Tumor greater than 10 mm but not more than 16 mm in greatest basal diameter and between 2.5 and 10 mm in maximum height (thickness) (ciliary body and choroid) (uveal melanoma) | |
| 399400003 | pT3: Tumor having extraparenchymal extension, and/or more than 4 cm but not more than 6 cm in greatest dimension, without seventh nerve involvement (major salivary glands) | |
| 399401004 | Insufficient tissue to assess highest pT category | |
| 399404007 | pT3b (IIIB): Tumor involves one or both fallopian tubes, with macroscopic peritoneal metastasis outside the pelvis 2 cm or less in greatest dimension (TNM category and FIGO stage) (fallopian tube) | |
| 399410007 | pT3c (IIIC): Tumor involves one or both fallopian tubes, with peritoneal metastasis outside the pelvis more than 2 cm in diameter (TNM category and FIGO stage) (fallopian tube) | |
| 399413009 | Thyroid TNM finding | |
| 399425007 | pT1a (IA): Tumor limited to one fallopian tube, without penetrating the serosal surface; no ascites (TNM category and FIGO stage) (fallopian tube) | |
| 399439007 | pT1: Tumor 2 cm or less in greatest dimension limited to the thyroid (thyroid) | |
| 399446003 | pT4b: Tumor invades prevertebral fascia or encases carotid artery or mediastinal vessels (thyroid) | |
| 399448002 | pT1: Tumor 10 mm or less in greatest diameter and 2.5 mm or less in greatest height (thickness) (ciliary body and choroid) (uveal melanoma) | |
| 399452002 | pM1b: Distant metastasis (esophagus) | |
| 399453007 | No pT1 category, insufficient tissue (prostate) | |
| 399454001 | pT1c (IC): Tumor limited to one or both tubes with extension onto or through the tubal serosa, or with malignant cells in ascites or peritoneal washings (TNM category and FIGO stage) (fallopian tube) | |
| 399461002 | pT1b: Tumor 10 mm or less in greatest diameter and 2.5 mm or less in greatest height (thickness) with microscopic extraocular extension (ciliary body and choroid) (uveal melanoma) | |
| 399474008 | pT2a: Tumor confluent with or extending into the ciliary body and/or choroid with melanomalytic glaucoma (iris) (uveal melanoma) | |
| 399478006 | pT1 (I): Tumor limited to the fallopian tube(s) (TNM category and FIGO stage) (fallopian tube) | |
| 399481001 | pN1a: Metastasis to level VI (pretracheal, paratracheal, and prelaryngeal/Delphian lymph nodes) (thyroid) | |
| 399493005 | pT1c: Tumor 10 mm or less in greatest diameter and 2.5 mm or less in greatest height (thickness) with macroscopic extraocular extension (ciliary body and choroid) (uveal melanoma) | |
| 399501001 | pT1: Tumor limited to the iris (iris) (uveal melanoma) | |
| 399508007 | pT4b: Extrathyroidal anaplastic carcinoma - surgically unresectable (anaplastic carcinoma) (thyroid) | |
| 399511008 | pT1b: Tumor limited to the iris (more than 3 clock hours in size) (iris) (uveal melanoma) | |
| 399516003 | pT1a: Tumor 10 mm or less in greatest diameter and 2.5 mm or less in greatest height (thickness) without microscopic extraocular extension (ciliary body and choroid) (uveal melanoma) | |
| 399517007 | Tumor stage cannot be determined | |
| 399518002 | pT2: Tumor more than 2 cm but not more than 4 cm in greatest dimension limited to the thyroid (thyroid) | |
| 399519005 | pT2a: Tumor 10 mm to 16 mm in greatest basal diameter and between 2.5 and 10 mm in maximum height (thickness) without microscopic extraocular extension (ciliary body and choroid) (uveal melanoma) | |
| 399543008 | pT2c: Tumor 10 mm to 16 mm in greatest basal diameter and between 2.5 and 10 mm in maximum height (thickness) with macroscopic extraocular extension (ciliary body and choroid) (uveal melanoma) | |
| 399553009 | pN3: Metastasis in a lymph node, more than 5 cm in greatest dimension (urinary bladder, ureter, renal pelvis) | |
| 399557005 | pT3: Tumor confluent with or extending into the ciliary body and/or choroid with scleral extension (iris) (uveal melanoma) | |
| 399575006 | pT4a: Intrathyroidal anaplastic carcinoma - surgically resectable (anaplastic carcinoma) (thyroid) | |
| 399594001 | pM1a: Distant metastasis (esophagus) | |
| 399597008 | pT1a: Tumor limited to the iris (not more than 3 clock hours in size) (iris) (uveal melanoma) | |
| 399602001 | pT1c: Tumor limited to the iris with melanomalytic glaucoma (iris) (uveal melanoma) | |
| 399605004 | FIGO stage finding for fallopian tube tumor | |
| 399610000 | pT3: Tumor more than 16 mm in greatest diameter and/or greater than 10 mm in maximum height (thickness) without extraocular extension (ciliary body and choroid) (uveal melanoma) | |
| 399615005 | pT2: Tumor confluent with or extending into the ciliary body and/or choroid (iris) (uveal melanoma) | |
| 399616006 | pT2b: Tumor 10 mm to 16 mm in greatest basal diameter and between 2.5 and 10 mm in maximum height (thickness) with microscopic extraocular extension (ciliary body and choroid) (uveal melanoma) | |
| 399621009 | pT3a (IIIA): Tumor involves one or both fallopian tubes, with microscopic peritoneal metastasis outside the pelvis (TNM category and FIGO stage) (fallopian tube) | |
| 399623007 | pT4a: Tumor of any size extending beyond the thyroid capsule to invade subcutaneous soft tissues, larynx, trachea, esophagus, or recurrent laryngeal nerve (thyroid) | |
| 399630001 | pT category not identified | |
| 399636007 | pT3c and/or N1 (IIIC): Tumor involves one or both fallopian tubes, with peritoneal metastasis outside the pelvis more than 2 cm in diameter AND/OR regional lymph node metastasis (TNM category and FIGO stage) (fallopian tube) | |
| 399641004 | pT2 (II): Tumor involves one or both fallopian tubes with pelvic extension (TNM category and FIGO stage) (fallopian tube) | |
| 399674004 | pT3a: Tumor confluent with or extending into the ciliary body and/or choroid with scleral extension and melanomalytic glaucoma (iris) (uveal melanoma) | |
| 399678001 | pT3 (III): Tumor involves one or both fallopian tubes, with peritoneal implants outside the pelvis (TNM category and FIGO stage) (fallopian tube) | |
| 399679009 | pT4: Tumor with extraocular extension (iris) (uveal melanoma) | |
| 399688000 | Fallopian tube TNM finding | |
| 399690004 | pT2b (IIB): Tumor involves one or both fallopian tubes with extension to other pelvic structures (TNM category and FIGO stage) (fallopian tube) | |
| 399696005 | pT3 and/or N1 (III): Tumor involves one or both fallopian tubes, with peritoneal implants outside the pelvis AND/OR regional lymph node metastasis (TNM category and FIGO stage) (fallopian tube) | |
| 399697001 | pT2c (IIC): Tumor involves one or both fallopian tubes with pelvic extension with malignant cells in ascites or peritoneal washings (TNM category and FIGO stage) (fallopian tube) | |
| 399704006 | pN1b: Metastasis to unilateral, bilateral, or contralateral cervical or superior mediastinal lymph nodes (thyroid) | |
| 399705007 | Uveal melanoma TNM finding | |
| 399729000 | pT4: Tumor more than 16 mm in greatest diameter and/or greater than 10 mm in maximum height (thickness) with extraocular extension (ciliary body and choroid) (uveal melanoma) | |
| 399736004 | pT1b (IB): Tumor limited to both tubes, without penetrating the serosal surface; no ascites (TNM category and FIGO stage) (fallopian tube) | |
| 399749009 | Any T/Any N and M1 (IV): Distant metastasis including presence of malignant cells in pleural fluid or parenchymal hepatic metastasis (TNM category and FIGO stage) (fallopian tube) | |
| 404180008 | pT3: Tumor invades beyond muscularis into peripelvic fat or renal parenchyma (renal pelvis) | |
| 404181007 | pM1 (IV): Distant metastasis (TNM category and FIGO stage) (fallopian tube) | |
| 404182000 | pM1 (IVB): Distant metastasis (TNM category and FIGO stage) (uterine cervix) | |
| 405917009 | Intergroup rhabdomyosarcoma study post-surgical clinical group finding | |
| 405918004 | Intergroup rhabdomyosarcoma study post-surgical clinical group not applicable | |
| 405919007 | Intergroup rhabdomyosarcoma study post-surgical clinical group cannot be assessed | |
| 405957007 | Intergroup rhabdomyosarcoma study post-surgical clinical group IA: localized tumor, confined to site of origin, completely resected | |
| 405958002 | Intergroup rhabdomyosarcoma study post-surgical clinical group IB: localized tumor, infiltrating beyond site of origin, completely resected | |
| 405959005 | Intergroup rhabdomyosarcoma study post-surgical clinical group IIA: localized tumor, gross total resection, but with microscopic residual disease | |
| 405960000 | Intergroup rhabdomyosarcoma study post-surgical clinical group IIB: Locally extensive tumor (spread to regional lymph nodes), completely resected | |
| 405961001 | Intergroup rhabdomyosarcoma study post-surgical clinical group IIC: Locally extensive tumor (spread to regional lymph nodes), gross total resection, but microscopic residual disease | |
| 405962008 | Intergroup rhabdomyosarcoma study post-surgical clinical group IIIA: Localized or locally extensive tumor, gross residual disease after biopsy only | |
| 405963003 | Intergroup rhabdomyosarcoma study post-surgical clinical group IIIB: Localized or locally extensive tumor, gross residual disease after major resection (greater than 50% debulking) | |
| 405964009 | Intergroup rhabdomyosarcoma study post-surgical clinical group IV: Any size primary tumor, with or without regional lymph node involvement, with distant metastases, without respect to surgical approach to primary tumor | |
| 405992004 | pN1 (IIIC): Regional lymph node metastasis (TNM category and FIGO stage) (ovary) | |
| 406001009 | pT4b: Tumor invades lateral pterygoid muscle, pterygoid plates, lateral nasopharynx, or skull base or encases internal carotid artery (oropharynx) | |
| 406088001 | pN0(i-): No regional lymph node metastasis histologically, negative morphologic findings for isolated tumor cells (breast) | |
| 406089009 | pN0(i+): No regional lymph node metastasis histologically, positive morphologic findings for isolated tumor cells, no cluster greater than 0.2 mm (breast) | |
| 406090000 | pN0(mol-): No regional lymph node metastasis histologically, negative nonmorphologic (molecular) findings for isolated tumor cells (breast) | |
| 406091001 | pN0(mol+): No regional lymph node metastasis histologically, positive nonmorphologic (molecular) findings for isolated tumor cells (breast) | |
| 406092008 | pN1 (IIIC): Regional lymph node metastasis (TNM category and FIGO stage) (fallopian tube) | |
| 409721000 | International neuroblastoma staging system stage finding | |
| 409722007 | International neuroblastoma staging system stage 1 | |
| 409723002 | International neuroblastoma staging system stage 2A | |
| 409724008 | International neuroblastoma staging system stage 2B | |
| 409725009 | International neuroblastoma staging system stage 3 | |
| 409726005 | International neuroblastoma staging system stage 4 | |
| 409727001 | International neuroblastoma staging system stage 4S | |
| 409747009 | pT1a: Tumor 5 cm or less in greatest dimension, superficial tumor (extraosseous primitive neuroectodermal tumor/Ewing's sarcoma) | |
| 409748004 | pT1: Tumor 5 cm or less in greatest dimension (extraosseous primitive neuroectodermal tumor/Ewing's sarcoma) | |
| 409749007 | pT1b: Tumor 5 cm or less in greatest dimension, deep tumor (extraosseous primitive neuroectodermal tumor/Ewing's sarcoma) | |
| 409750007 | pT2: Tumor more than 5 cm in greatest dimension (extraosseous primitive neuroectodermal tumor/Ewing's sarcoma) | |
| 409751006 | pT2a: Tumor more than 5 cm in greatest dimension, superficial tumor (extraosseous primitive neuroectodermal tumor/Ewing's sarcoma) | |
| 409752004 | pT2b: Tumor more than 5 cm in greatest dimension, deep tumor (extraosseous primitive neuroectodermal tumor/Ewing's sarcoma) | |
| 409753009 | pT1: Tumor 8 cm or less in greatest dimension (osseous primitive neuroectodermal tumor/Ewing's sarcoma) | |
| 409754003 | pT2: Tumor more than 8 cm in greatest dimension (osseous primitive neuroectodermal tumor/Ewing's sarcoma) | |
| 409755002 | pT3: Discontinuous tumors in the primary bone site (osseous primitive neuroectodermal tumor/Ewing's sarcoma) | |
| 409756001 | Primitive neuroectodermal tumor/Ewing's sarcoma TNM finding | |
| 409758000 | pM1a: Distant metastasis to lung (primitive neuroectodermal tumor/Ewing's sarcoma) | |
| 409759008 | pM1b: Distant metastasis to site other than lung (primitive neuroectodermal tumor/Ewing's sarcoma) | |
| 422375001 | Carcinoma of colon, stage III | |
| 422399001 | Infiltrating ductal carcinoma of breast, stage 1 | |
| 422479008 | Infiltrating ductal carcinoma of breast, stage 2 | |
| 422581008 | Carcinoma of colon, stage II | |
| 422679002 | Seminoma of testis, stage 3 | |
| 422807001 | pT4: Tumor directly invades other organs or structures and/or perforates visceral peritoneum (appendix) | |
| 422901001 | pTis: Carcinoma in situ, intraepithelial (appendix) | |
| 422985007 | Carcinoma of colon, stage IV | |
| 423003009 | pT3: Tumor invades through the muscularis propria into the subserosa or into mesoappendix (appendix) | |
| 423055005 | pTis: Carcinoma in situ, invasion of lamina propria (appendix) | |
| 423114009 | Infiltrating ductal carcinoma of breast, stage 3 | |
| 423274005 | Carcinoma of ovary, stage 4 | |
| 423480004 | Carcinoma of ovary, stage 3 | |
| 423645007 | Seminoma of testis, stage 2 | |
| 423697000 | Seminoma of testis, stage 4 | |
| 423816008 | Seminoma of testis, stage 1 | |
| 424078005 | Adenocarcinoma of lung, stage I | |
| 424229006 | Infiltrating ductal carcinoma of breast, stage 4 | |
| 424454009 | Adenocarcinoma of lung, stage III | |
| 424486004 | Carcinoma of ovary, stage 2 | |
| 424600001 | Carcinoma of ovary, stage 1 | |
| 424632001 | Adenocarcinoma of lung, stage II | |
| 424842001 | pT1: Tumor invades submucosa (appendix) | |
| 424993006 | Adenocarcinoma of lung, stage IV | |
| 425008003 | pT2: Tumor invades muscularis propria (appendix) | |
| 425037004 | Low grade lymphoma, stage 1 | |
| 425213009 | Carcinoma of colon, stage I | |
| 425566006 | pT1b: Tumor 5 cm or less in greatest dimension, deep tumor (soft tissue) | |
| 426288003 | pM1b: Distant metastasis to site other than lung (bone) | |
| 426554005 | pT2b: Tumor more than 5 cm in greatest dimension, deep tumor (soft tissue) | |
| 426561009 | Bone TNM finding | |
| 426613005 | pT2a: Tumor more than 5 cm in greatest dimension, superficial tumor (soft tissue) | |
| 426616002 | pT2: Tumor more than 8 cm in greatest dimension (bone) | |
| 426897009 | pT1: Tumor 8 cm or less in greatest dimension (bone) | |
| 426917009 | pM1a: Distant metastasis to lung (bone) | |
| 427209003 | pT3: Discontinuous tumors in the primary bone site (bone) | |
| 427495001 | pT1a: Tumor 5 cm or less in greatest dimension, superficial tumor (soft tissue) | |
| 427535001 | Soft tissue TNM finding | |
| 443335006 | pN0(i-) category | |
| 443357004 | pT1a category | |
| 443452006 | pN2b category | |
| 443479005 | pT3d category | |
| 443486002 | pN0(i+) category | |
| 443505003 | pT4d category | |
| 443506002 | pT1b category | |
| 443599002 | pN1b category | |
| 443600004 | pT1mic category | |
| 443604008 | pT4a category | |
| 443606005 | pT3a category | |
| 443642002 | pT1c category | |
| 443674009 | pT3c category | |
| 443716008 | pN1a category | |
| 443721006 | pT4c category | |
| 443736009 | pT4b category | |
| 443743003 | pN1c category | |
| 443784000 | pT3c,d category | |
| 443812002 | pT2a category | |
| 443815000 | pT3a,b category | |
| 443817008 | pT3b category | |
| 443823003 | pN3c category | |
| 443824009 | pN1mi category | |
| 443839005 | pM1c category | |
| 443840007 | pM1b category | |
| 443841006 | pM1a category | |
| 443866005 | pN3a category | |
| 443867001 | pN2a category | |
| 443875007 | pN0(mol+) category | |
| 443893008 | pN2c category |
See the full registry of value sets defined as part of FHIR.
Explanation of the columns that may appear on this page:
| Lvl | A few code lists that FHIR defines are hierarchical - each code is assigned a level. For value sets, levels are mostly used to organize codes for user convenience, but may follow code system hierarchy - see Code System for further information |
| Source | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
| Code | The code (used as the code in the resource instance). If the code is in italics, this indicates that the code is not selectable ('Abstract') |
| Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
| Definition | An explanation of the meaning of the concept |
| Comments | Additional notes about how to use the code |
FHIR ®© HL7.org 2011+. FHIR R5 Preview #3 hl7.fhir.core#4.5.0 generated on Thu, Aug 20, 2020 17:43+1000.
Links: Search |
Version History |
Table of Contents |
QA Page |
Compare to R4 |
|
Propose a change